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ABSTRACT 
Obesity is a preventable cause of morbidity and mortality and affects over one-third of 
the American adult population.  Eating rate and ghrelin concentrations are two 
variables that may play a role in obesity.  An ancillary study of female college 
students examined the differences in eating rate (grams/second) and fasting plasma 
ghrelin concentrations (pg/mL) between weight status categories (normal weight body 
mass index (BMI) = 18.5-24.9 kg/m2, overweight BMI = 25-29.9 kg/m2 and obese 
BMI ≥ 30 kg/m2). Anthropometrics, clinical (blood pressure), and biochemical 
(glucose and ghrelin) data were assessed.  Dietary information was obtained from 
three non-consecutive 24-hour recalls using the multiple pass method in conjunction 
with the Nutrition Data System for Research. Physical activity was assessed using the 
International Physical Activity Questionnaire Short Form.  Primary outcomes were 
assessed using a one-way analysis of variance.  Mean age, BMI and waist 
circumference for the 78 participants were 18.8±0.9 years, 27.9±5.5 kg/m2, and 
87.4±13.9 inches, respectively.  Mean eating rate and ghrelin concentrations were 
0.26±0.13 grams (gms)/second and 216.2±269.9 pg/mL, respectively.  Mean energy 
intake, food intake and physical activity were 1,731.9±507.1 kcals, 6,365.2±2,590.5 
gms, and 2,542.6±2,107.5 MET-minutes/week, respectively.  Mean energy density 
was 1.25±0.3 kcal/gm. There were no differences (p=0.49) in eating rate across weight 
status categories.  Ghrelin concentrations were significantly different between 
overweight and obese groups; 217.1±106.6 vs. 150.1±77.4 pg/mL (p<0.05).  Future 
studies in the college-aged population are warranted to determine the nature of these 
relationships in providing a basis for future studies in targets for weight maintenance 
and energy homeostasis. 
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PREFACE 
 This thesis was written to comply with the University of Rhode Island graduate 
school Manuscript Thesis Format.  This thesis contains one manuscript: Eating rate, 
fasting ghrelin concentrations and weight status in female college students from the 
University of Rhode Island.  This manuscript has been written in a form suitable for 
publication in the Obesity journal. 
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Abstract: 
Obesity is a preventable cause of morbidity and mortality and affects over one-third of 
the American adult population.  Eating rate and ghrelin concentrations are two 
variables that may play a role in obesity.  An ancillary study of female college 
students examined the differences in eating rate (grams/second) and fasting plasma 
ghrelin concentrations (pg/mL) between weight status categories (normal weight body 
mass index (BMI) = 18.5-24.9 kg/m2, overweight BMI = 25-29.9 kg/m2 and obese 
BMI ≥ 30 kg/m2). Anthropometrics, clinical (blood pressure), and biochemical 
(glucose and ghrelin) data were assessed.  Dietary information was obtained from 
three non-consecutive 24-hour recalls using the multiple pass method in conjunction 
with the Nutrition Data System for Research. Physical activity was assessed using the 
International Physical Activity Questionnaire Short Form.  Primary outcomes were 
assessed using a one-way analysis of variance.  Mean age, BMI and waist 
circumference for the 78 participants were 18.8±0.9 years, 27.9±5.5 kg/m2, and 
87.4±13.9 inches, respectively.  Mean eating rate and ghrelin concentrations were 
0.26±0.13 grams (gms)/second and 216.2±269.9 pg/mL, respectively.  Mean energy 
intake, food intake and physical activity were 1,731.9±507.1 kcals, 6,365.2±2,590.5 
gms, and 2,542.6±2,107.5 MET-minutes/week, respectively.  Mean energy density 
was 1.25±0.3 kcal/gm. There were no differences (p=0.49) in eating rate across weight 
status categories.  Ghrelin concentrations were significantly different between 
overweight and obese groups; 217.1±106.6 vs. 150.1±77.4 pg/mL (p<0.05).  Future 
studies in the college-aged population are warranted to determine the nature of these 
relationships in providing a basis for future studies in targets for weight maintenance 
and energy homeostasis. 
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Introduction 
Obesity and overweight are preventable causes of morbidity and mortality and 
affect over two-thirds of the American adult population (1).  College students, 
traditionally between the ages of 18 and 24, are a population of interest as they 
experience the most rapid weight gain (2) with a mean weight gain of 0.73 lbs/month, 
a rate 36 times faster than same-aged non-college females (3).  Female college 
students gain more weight in less time than their male counterparts (4), from 2.2 
pounds in the first six months to 9.2 pounds in the first year (2, 5) due to lifestyle 
changes that affect diet and physical activity, when transitioning from high school to 
college (6).  Dietary and physiological factors that may be associated with increased 
female weight status are still unclear and research is limited looking at free-living 
female populations.   
One factor associated with weight status is the appetite-stimulating hormone 
ghrelin; as ghrelin shifts with changes in weight and controls appetite. To date, ghrelin 
is the first and only peripheral hormone to display increasing orexigenic, or appetite 
stimulating, effects through the hypothalamic appetite-regulating pathway (7), which 
has advanced research related to its impact on appetite enhancement and energy 
homeostasis. Ghrelin is highly associated with body weight regulation; concentrations 
increase before and decrease after food intake, proportional to calories and 
macronutrients consumed (8).   Also, obese individuals are shown to have lower 
fasting ghrelin concentrations than leaner individuals, suggesting that weight status 
impacts ghrelin (9).  Cummings et al. (9) observed mean area under the curve for 
ghrelin increased 24% (p =0.006) with a mean weight loss of 17.4±1.5% from baseline 
following a 6-month weight loss program in obese participants.   Similarly, Hansen et 
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al. (10) noted fasting ghrelin in obese individuals increased 12% (114±17 fmol/ml vs. 
128±16 fmol/ml, p<0.01) following a 6-month weight loss intervention class.  Obese 
individuals who lose even 5% of their body weight significantly increase circulating 
ghrelin (11).  Exploring the effects of weight status on ghrelin concentrations more 
closely is essential to better understand its physiological control of feeding, which may 
lead to its therapeutic possibilities related to maintaining body weight.  Likewise, 
exploring ghrelin’s relationship with variables that may influence weight status, such 
as eating behaviors, may be important for weight management recommendations.  
Eating rate can be defined as the amount of food consumed (gms) within a 
certain amount of time (seconds) (12).  Eating rate could affect energy intake because 
adopting a slower eating rate may enhance satiety by allowing gastrointestinal 
peptides to register meal satiation (13).  Research shows obese individuals take larger 
and faster bites than lean individuals, possibly contributing to overconsumption and 
increased body weight (14).  
Though ghrelin and eating rate have been examined individually in relation to 
weight status, there is little evidence focusing on these two variables together (15, 16).  
Sobki et al. (15) reported participants with a slow eating rate had persistent elevations 
in ghrelin concentrations compared to those with a normal eating speed.  However, 
Kokkinos et al. (16) reported no significant differences (p=0.3) in ghrelin 
concentrations after the same test meal was consumed at a two different meal 
durations.  These two studies on eating rate and ghrelin have mostly been observed in 
controlled settings; however, there is no focus in free-living individuals.  More 
exploratory research is needed to determine differences among weight status, ghrelin 
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and eating rate to provide novel insights in attenuating unhealthy weight gain in young 
adult college population.   
The purpose of this study is to examine the differences in eating rate and 
ghrelin concentrations between weight status categories in free-living female college 
students (normal weight body mass index (BMI) = 18.5-24.9 kg/m2, overweight BMI 
= 25-29.9 kg/m2 and obese BMI ≥ 30 kg/m2).  Secondary aims were to examine the 
relationships between ghrelin and eating rate, as well a relationship between eating 
rate and energy density of meals.  Exploratory research for effects of weights status on 
total daily eating time, energy and food intake as well the relationship between ghrelin 
and IPAQ-S scores will also be determined.  Based on previous research, we 
hypothesize that obese college females will have a faster eating rate, as well as lower 
ghrelin concentrations, than overweight and normal weight college females. 
 
Methods and Procedures 
Study Design 
 This research is a cross-sectional ancillary study examining the relationships 
among weight status, ghrelin concentrations, and eating rate.  Data for the present 
study were obtained from two other studies performed at the University of Rhode 
Island (URI): the Best Food Forward (BFF) and the Nutritional Assessment and 
Chronic Disease Risk Factor Identification (Hatch) studies. The BFF study was a 
randomized clinical trial and examined the effectiveness of a self-taught intervention 
versus an instructed intervention on coronary heart disease (CHD) risk in 
overweight/obese females at URI, however only baseline data were used in this study.  
The Hatch study was cross-sectional and determined the prevalence of metabolic 
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syndrome and CHD risk factors and their relationship to dietary intake and physical 
activity in first year URI students. 
Participants 
 Seventy-eight female participants were analyzed for this study (26 normal 
weight, 26 overweight, and 26 obese).  Prior to each of the studies, participants from 
each study read and signed the appropriate informed consent; both studies were 
approved by URI’s Institutional Review Board.  Participants were recruited via flyers 
posted around campus and in residence halls, student newspaper advertisements, 
presentations made in introductory science classes, and booths at the student union, 
job fairs and dining halls.  Eligibility criteria included not being pregnant or lactating, 
having no diagnoses of CHD, diabetes, liver disease, kidney disease, bleeding 
disorders, not taking any lipid-lowering medications or having a history of an eating 
disorder.  The BFF study needed to have a BMI between 25-39.9 kg/m2 while the 
Hatch study had no BMI parameters. 
Anthropometrics 
 All anthropometric measures were conducted in duplicate.  Height was 
measured to the nearest 0.2 cm using a 220 stadiometer (Seca Corporation, Hamburg, 
Germany) and waist circumference was measured to the nearest 0.2 cm using a Gulick 
non-stretchable tape measure with an attached tensometer at the top of the iliac crest 
upon exhalation (Patterson Medical, Mouth Joy, PA).  For the Hatch study, weight 
was measured using a calibrated digital Seca 769 scale (Seca Corporation, Hamburg, 
Germany) to the nearest 0.2 kg; for the BFF study, weight was measured to the nearest 
0.1 kg using a calibrated digital read scale (Bod Pod, Version 2.14, Body Composition 
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System; Life Measurement Instruments, Concord, CA).  Height and weight were used 
to calculate participant BMI (weight in kilograms/height in meters2). 
Biochemical 
A trained phlebotomist conducted two 12-hour fasted venous blood draws on 
two nonconsecutive morning visits in the same week with each participant.  Samples 
were processed according to the following protocol (17).  Briefly, plasma was 
obtained from whole blood via centrifugation (Eppendorf Centrifuge 5810, Germany) 
for 20 minutes at 2200 RPM’s at 4oC. The following preservation cocktail was added 
to the plasma samples: 0.01g/100g of phenylmethylsulfonyl fluoride (Roche, 
Indianapolis, IN), 0.01g/100g of sodium azide (Fisher, Fairlawn, NJ) and 0.05g/100g 
of aprotinin (Fisher, Fairlawn, NJ) samples were aliquoted into separate 500µL 
aliquots and were then stored at -80° until analyses.   
            Enzymatic assays were performed on glucose (GLC) concentrations were 
analyzed using a Wako Glucose Autokit (Wako Diagnostics, Richmond, VA) (18), 
and read in a Biotek ELX 808 plate reader (Biotek, Winooski, VT).  Fasting ghrelin 
concentrations were analyzed using an enzyme-linked immunosorbent assay (ELISA) 
kit (manufactured by SPI-Bio, Montigny le Bretonneux, France and distributed by 
ALPCO Diagnostics, Salem, NH). 
Clinical 
 Resting blood pressure (BP) was measured by a trained exercise physiologist 
after a five-minute seated rested period using a stethoscope (Littman, St. Paul, MN) an 
appropriately sized BP cuff (Fisher Scientific, Fairlawn, NJ and Welch-Allyn, 
Skaneateles Falls, NY).  Blood pressure was measured in duplicate unless variance 
between measures exceeded the standard (two mmHg), in which case the 
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measurement was repeated.  The average of the two readings within the standard was 
used for data analysis. 
Dietary and Physical Activity 
Data collected from three 24 hour recalls (24HR) from each participant, using 
NDSR version 2007, 2008, and 2009 software (Nutrition Coordinating Center, 
University of Minnesota, Minneapolis, MN), were used to calculate a mean eating rate 
for each participant.  The differences between the NDSR versions only pertains the 
food database that is updated with more food choices each year.  All study participants 
completed three 24HR recalls: one in-person and two over the phone, collected by 
trained study personnel.  Recalls were collected on three non-consecutive days (two 
weekdays and one weekend day); this method has been shown to provide a good 
estimate of an individual’s usual intake (19).  During the face-to-face interview, Nasco 
food models (eNASCO, Fort Atkinson, WI) were used to assist with portion size 
estimation.  Participants also received food amount booklets designed by the Nutrition 
Coordinating Center at the University of Minnesota at the first 24HR, which they kept 
for the additional 24HR’s. The food amounts booklets help participants estimate more 
accurate portion sizes.   
Eating rate was expressed as grams of food consumed per second and included 
all foods, and only beverages that provide ≥5 kilocalories per 100 grams (20).  In 
addition to the NDSR prompted questions, there were few questions asked, one of 
which included “How long did you spend eating this meal?”  That information was 
collected in minutes/meal, which then was computed to seconds/meal.  The total 
number of grams of food and seconds of meal consumption time were expressed as 
means per day.  The means of grams of food consumed and seconds of meal 
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consumption time were then averaged for a total mean of the three 24HRs.  Those two 
means were used to calculate grams of food consumed per second. 
Energy density included meals and snacks; including beverages containing ≥5 
kcals/100 grams (20). Energy density was calculated using average energy intake of 
the meal or snack (including beverages) in kcals divided by total food intake of the 
meal in grams, and expressed in kcals/gram.  The total number of kcals and grams 
were expressed as means per day.  The means of kcals of energy intake and grams of 
food intake were then averaged for a total mean of the three 24HRs.  Those two means 
were used to calculate kcals of energy intake per gram of food, which is how energy 
density was defined.   
Physical activity was measured using the International Physical Activity 
Questionnaire Short Form (IPAQ-S) and was scored based on the Guidelines for Data 
Processing and Analysis of the International Physical Activity Questionnaire (21).  
This tool has been validated in young adults to reflect habitual physical activity levels 
(21).  Participants were asked to report their frequency (days per week) and duration 
(time in minutes) of low, moderate, and vigorous physical activity over the past seven 
days. Physical activity is expressed in metabolic equivalents (METs) in 
METs/minute/week (METs-min/wk); METs-min is the product of the MET score of 
an activity multiplied by the minutes performed.   
Statistical Analysis: 
One-way analyses of variance (ANOVA) for eating rate required 78 
participants to achieve a power of 0.8 with a large effect size f=0.4; an effect similar to 
that found by Laessle et al (2007), with an expected difference of 1.2 grams/second 
between normal weight and overweight/obese groups.  In order to have a total of 78 
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participants, 26 will be needed for each weight status classification: normal weight, 
overweight, and obese.  Significance was set at α=0.025 by applying the Bonferroni 
correction to account for power calculations. 
Data analyses were performed using the Statistical Package for the Social 
Sciences (SPSS) for Windows 19.0 (IBM Corp., Somers, NY).  Normality was 
assessed by examining skewness and kurtosis.   Outliers that were greater than three 
standard deviations from the mean were removed for TAG (n=1), IPAQ-S (n=2), 
percent kilocalories from fat (n=1), total grams (n=1), meal time (n=3), eating rate 
(n=3), energy density (n= 1), and ghrelin (n=1).  Continuous variables are displayed as 
means and standard deviations and categorical variables are displayed as frequencies 
and percentages. A one-way analysis of variance (ANOVA) determined the 
differences in participant descriptive characteristics across weight status categories. 
One way ANOVA’s were also used for both primary analyses; comparing eating rate 
as well as ghrelin across weight status categories.  Pearson’s correlations were used 
for the secondary aims to determine the relationships between eating rate and ghrelin 
and eating rate and energy density.  Exploratory statistics using an ANOVA examined 
the differences in total daily eating time, total food and energy intake across weight 
status categories, as well as a Pearson’s correlation to determine a relationship 
between ghrelin and IPAQ scores. Significance was set at p<0.05. 
Results 
 The descriptives for all 78 participants are presented as mean ± standard 
deviation in Table 1, and descriptives across weight status categories in Table 2.  
Fifty-eight participants identified themselves as white, eight (10%) as Black/African 
American, nine (12%) as Hispanic, and four (5%) as Other (data not shown). Mean 
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reported physical activity was 11,088±2,107.5 MET-minutes/week.  Mean total food 
intake, total energy intake, and total time spent eating/day were 1,420.1±476.8 
grams/day, 1,729.4±509.5 kcals/day, and 6,225.8±3,445.9 seconds/day, respectively 
(Table 3). 
 Mean eating rate was 0.29±0.21 grams/second (Table 3). There were no 
significant differences (p=0.62) in eating rate across weight status categories.  Ghrelin 
concentrations were significantly higher in the overweight than the obese group, 
217.1±106.6 vs. 150.1±77.4 pg/mL, respectively, with normal weight females having 
30.9% higher ghrelin concentrations (Figure 1).   
There was a significant inverse correlation (r=-0.385, p<0.01) between eating 
rate and energy density (Figure 2).  The average energy density of meals and snacks 
consumed did not differ among the different weight status categories, p=0.97 (data not 
shown).  The correlation was not significant (r=-0.082, p=0.48) for eating rate and 
ghrelin concentrations (data not shown).  Mean kcal/day as well as total food intake 
expressed as gms/day were significantly higher in the normal weight than the obese 
group; 1,965.5±528.0 kcal/day vs. 1,516.8±453.9 kcal/day (p<0.05) and 
1,631.6±532.1 gms/day vs. 1,257.3±419.1 gms/day (p<0.05), respectively (Table 3). 
No significant correlation was found between ghrelin and IPAQ-S scores (r=0.061, 
p=0.60) (data not shown).   
Discussion 
 To our knowledge, this is the first study that looks at the difference among 
weight status, with ghrelin and eating rate in the college-aged female population.  
Unexpectedly, eating rate was not different across weight status categories. The 
observed ghrelin differences support the finding that concentrations are significantly 
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lower in obese individuals.  The data observed between eating rate and ghrelin 
indicated no significant relationship.  Eating rate and energy density indicated a small 
inverse relationship which was opposite of what was anticipated. 
The expected difference of 1.2 grams/second we expected to find between 
normal weight and overweight/obese participants was not achieved, as we found 0.03 
grams/second (12).  This study measured differences in a laboratory setting and only 
used one test meal when determining the measurement of eating rate.  In the current 
study we reviewed dietary data from three 24-hour recalls allowing for more a variety 
of dietary intake and meal consumption time.  The dietary data also was collected 
using a self-reported method so this could have been a reason why we did not see a 
similar difference in eating rate between groups as the Laessle et al. study.   
It has been suggested that there is a distinctive eating style of obese individuals 
characterized by shorter meal duration, larger bite size and therefore rapid eating pace 
(22).  An earlier study found that body size positively correlates to eating responses, 
indicating that as body size increased there was an observed increased in the number 
of bites, bite size and bite speed (22).  Eating rate studies of obese and nonobese 
women in natural settings have also found non-significant findings (23, 24); however, 
no studies have observed this finding in self-reported dietary intake and meal duration.  
In earlier well-controlled test meal studies, food intake rate was measured in number 
of bites or chews over a certain amount of time (22).  These studies, however, reported 
few consistent eating differences between obese and nonobese participants in 
distinctive eating behaviors, and their sample sizes were relatively small (25).  
Additional research is needed to determine the generalization of the results to other 
populations, such as males, as eating rate is shown to differ by gender (26).  
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Several factors could have contributed to the contradictory findings seen in this 
study between obese and non-obese individuals.  First eating behavior studies have 
used different techniques, such as direct observation, lab measures, food diaries, self-
report questionnaires, which are known to have differing validity in different 
populations (25).  Most studies have primarily been done in research laboratories, 
versus in a more natural realistic setting (12, 22).  Lastly, many eating rate studies 
focus only on one meal, thus obscuring differences between normal and obese 
populations that may cause variability across different times and settings and 
individual meal patterns.  For future studies, repeated observation in a more natural 
environment will be beneficial in determining accurate eating styles between obese 
and non-obese individuals.    
Interestingly, ghrelin concentrations were significantly higher in overweight 
than obese females, there were no significant differences in normal weight females.  
Ghrelin concentrations being lower in obese individuals is consistent with other 
studies (27, 28), and seems to indicate that ghrelin is downregulated in obese 
individuals.  Though still unclear in research, decreased plasma ghrelin concentrations 
represent a physiological adaption to the positive energy balance maintained in obese 
individuals (29). This downregulation may be due, in part, to increased insulin and 
leptin, an anorexigenic or appetite suppressant hormone, concentrations; as ghrelin is 
inversely associated with these hormones (28).  Though insulin and leptin 
concentrations were not examined in this study, in the future they should be reviewed 
to clarify their relationships with outcomes related to the pathogenesis of obesity.  
There was a moderate negative correlation between eating rate and energy 
density; the lower the energy density the eating occasion the faster it was eaten.  This 
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finding is still unclear in research, however, Hogenkamp et al.(30) found when 
participants ate yogurt with a low energy density, their eating rate was significantly 
faster versus yogurt of a higher energy density.  This finding is interesting in the 
college-aged female population, as it is an environment to be conducive to high energy 
dense foods and adopting new dietary patterns.  There was a small but significant 
positive correlation between energy density and energy intake (r=0.295, p<0.01, data 
not shown), which is consistent with other findings (20, 31).   Exploring energy 
density and energy intake in populations, such as those in college, who are exposed to 
a variety of high energy dense foods may be a crucial step to weight management.  
There were no significant differences in energy density across weight status 
categories.  This may be partially due to the controversy with energy density in 
regards to beverages; beverages tend to have a lower energy density than food and can 
disproportionately influence energy density values (20).  When using methods that 
account for the exclusion or inclusion of water, energy density values can be 
underestimated as water provides no calories but a high volume.  The energy density 
method used in this study is used in a free-living population and found a significant 
positive relationship between energy density and total reported energy intake.  
Interpretations are highly variable and hard to compare between different studies as 
different methodologies are used (20, 32).  Future researchers must consistently define 
energy density methods to better understand their variability and relation to energy 
intake and weight status.  
Obese females reported lower energy intake than normal weight females 
(p<0.05).  This was unexpected, however, is noted in other studies (33, 34) that 
underreporting of dietary intake in obese participants is a frequent challenge in 
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nutrition research when using self-reported dietary assessment methods (35).  Obese 
individuals underreport their dietary intake by 20-50% (36) but little is known about 
how it can be prevented.  According to the National Health and Nutrition Examination 
Survey, adults with a BMI greater than 27.3 kg/m2 underreport energy intake more 
than adults with a lower BMI (37).  Kretsch et al. (37) concluded normal weight 
females underreported their energy intake by an average of 282 kcals/day and 
overweight females by 621 kcals/day, and when expressed in percentages of required 
energy intake, daily needs were underreported in normal weight and overweight 
females by 10% and 20%, respectively.  Furthermore, some studies have reported that 
women underreport their dietary intake to a greater extent than males (34, 38).  This 
could explain the present study’s finding of obese women reporting that they consume 
less energy and food intake than normal weight participants.  An explanation of why 
this occurs is still a question that remains unanswered in research; however, many 
psychological and physiological factors can occur such as weight conscientiousness, 
self-image, and social desirability.  These are all factors that should be taken into 
account when interpreting dietary assessment data in obese women and can be the 
result of inconsistent data. 
 Though there was no significant relationship between ghrelin and IPAQ-S 
scores, it is still imperative to examine due to the fact that exercise has been shown to 
influence energy balance and therefore influences ghrelin levels (39).  Previous 
research has indicated that ghrelin concentrations are increased in response to a 
negative energy balance (9); therefore it can be hypothesized that physically fit 
individuals will have higher concentrations.  Inverse to under-reported dietary intake, 
obese individuals have a tendency to overestimate their physical activity, which can 
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result in misinterpretation of true habitual physical activity (40).  Research 
necessitates further exploration on the effects of exercise and more direct measures of 
physical activity for understanding their interactions in body weight regulation.     
There were some limitations to this study.  Most eating rate studies are 
conducted in well-controlled laboratory settings, where food intake or eating condition 
is manipulated or standardized and the mealtime and weight of a meal is calculated by 
the researcher.  This study focused on eating rate in free-living occasions with 
reported mealtime and energy intake reliant on memory, however, we used 24-hour 
recalls, a method that has been shown to be very accurate.  This study may also lack 
generalizability since it only examined college-aged females; more research is needed 
in larger more diverse college populations.  
 In spite of these limitations, this study has several strengths.  First, the nature 
of this ancillary study allowed for this study to be on the larger side (n=78) with equal 
weight status categories (n=26 per group) compared to sample sizes seen in other 
studies conducted in this area of research. Second, data was collected during both the 
fall-spring semesters (96% in the 2009-2010 academic year), allowing for a full 
academic year of dietary patterns to be reviewed.   
 In summary, we examine for the first time the college age female weight 
status, fasting ghrelin concentrations as well as self-reported eating rate.  The findings 
of this study conclude that ghrelin concentrations are significantly lower in obese 
females than nonobese females and may be a target for body weight regulation.  
Though eating rate did not differ between weight status categories in this study, it is 
still imperative to review in the future as it influences energy homeostasis, which is 
positively associated to weight status.  Future studies in the college-aged population 
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are warranted to determine the nature of these relationships in providing a basis for 
future studies on targets for weight maintenance interventions.  
 
Disclosure Statement 
There were no conflicts of interest in this study. 
 
Literatures Cited 
 
1. Ogden CL, Carroll MD, McDowell MA, Flegal KM. Obesity among adults in 
the United States--no statistically significant chance since 2003-2004. NCHS Data 
Brief. 2007 Nov(1):1-8. 
2. Racette SB, Deusinger SS, Strube MJ, Highstein GR, Deusinger RH. Changes 
in weight and health behaviors from freshman through senior year of college. J Nutr 
Educ Behav. 2008 Jan-Feb;40(1):39-42. 
3. Hovell MF, Mewborn CR, Randle Y, Fowler-Johnson S. Risk of excess weight 
gain in university women: a three-year community controlled analysis. Addict Behav. 
1985;10(1):15-28. 
4. World Health Organization: Obesity: preventing and managing the global 
epidemic.  Report of a WHO consultation. . World Health Organ Tech Rep Ser. 
2000;894:1-253. 
5. Lloyd-Richardson EE, Bailey S, Fava JL, Wing R. A prospective study of 
weight gain during the college freshman and sophomore years. Prev Med. 2009 
Mar;48(3):256-61. 
18 
 
6. Butler SM, Black DR, Blue CL, Gretebeck RJ. Change in diet, physical 
activity, and body weight in female college freshman. Am J Health Behav. 2004 Jan-
Feb;28(1):24-32. 
7. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A 
role for ghrelin in the central regulation of feeding. Nature. 2001 Jan 
11;409(6817):194-8. 
8. Castaneda TR, Tong J, Datta R, Culler M, Tschop MH. Ghrelin in the 
regulation of body weight and metabolism. Front Neuroendocrinol. 2010 Jan;31(1):44-
60. 
9. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, et al. 
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl 
J Med. 2002 May 23;346(21):1623-30. 
10. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS, et al. 
Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol 
(Oxf). 2002 Feb;56(2):203-6. 
11. Cummings DE, Shannon MH. Roles for ghrelin in the regulation of appetite 
and body weight. Arch Surg. 2003 Apr;138(4):389-96. 
12. Laessle RG, Lehrke S, Duckers S. Laboratory eating behavior in obesity. 
Appetite. 2007 Sep;49(2):399-404. 
13. Martin CK, Anton SD, Walden H, Arnett C, Greenway FL, Williamson DA. 
Slower eating rate reduces the food intake of men, but not women: implications for 
behavioral weight control. Behav Res Ther. 2007 Oct;45(10):2349-59. 
14. Spiegel TA. Rate of intake, bites, and chews-the interpretation of lean-obese 
differences. Neurosci Biobehav Rev. 2000 Mar;24(2):229-37. 
19 
 
15. Sobki SH, Zaid AA, Khan HA, Alhomida AS, Hilal KA, Khan SA. Significant 
impact of pace of eating on serum ghrelin and glucose levels. Clin Biochem. 2010 
Mar;43(4-5):522-4. 
16. Kokkinos A, le Roux CW, Alexiadou K, Tentolouris N, Vincent RP, Kyriaki 
D, et al. Eating slowly increases the postprandial response of the anorexigenic gut 
hormones, peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab.  
Jan;95(1):333-7. 
17. Lofgren IE HK, West KL, Zern TL, Patalay M, Koo SI, Fernandez ML. 
Carbohydrate intake is correlated with biomarkers for coronary heart disease in a 
population of overweight premenopausal women. Journal of Nutrition Biochemistry. 
2005;16:245-50. 
18. Reljic R RM, Anic N, Ries B. New chromogen for assay of glucose in serum. 
Clin Chem. 1992;38:522-5. 
19. Nelson M, Black AE, Morris AD, Cole TJ. Between- and within-subject 
variation in nutrient intake from infancy to old age: estimating the number of days 
required to rank dietary intakes with desired precision. Am J Clin Nutr. 1989;50:155-
67. 
20. Ledikwe JH, Blanck HM, Khan LK, Serdula MK, Seymour JD, Tohill BC, et 
al. Dietary energy density determined by eight calculation methods in a nationally 
representative United States population. J Nutr. 2005 Feb;135(2):273-8. 
21. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, 
et al. International physical activity questionnaire: 12-country reliability and validity. 
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. 
20 
 
22. Hill SW, McCutcheon NB. Contributions of obesity, gender, hunger, food 
preference, and body size to bite size, bite speed, and rate of eating. Appetite. 1984 
Jun;5(2):73-83. 
23. Dodd DK, Birky HJ, Stalling RB. Eating behavior of obese and normal-weight 
females in a natural setting. Addict Behav. 1976;1(4):321-5. 
24. Adams N, Ferguson J, Stunkard AJ, Agras S. The eating behavior of obese and 
nonobese women. Behav Res Ther. 1978;16(4):225-32. 
25. Wing RR, Carrol C, Jeffrey RW. Repeated observation of obese and normal 
subjects eating in the natural environment. Addict Behav. 1978;3(3-4):191-6. 
26. Martin C AS, Walden H, Arnett C, Williamson D. Does slower eating rate 
reduce food intake? Obes Res. 2004;12(A6):22-OR. 
27. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, et al. 
Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin 
secretion. J Clin Endocrinol Metab. 2002 Jan;87(1):240-4. 
28. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. 
Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001 
Apr;50(4):707-9. 
29. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the 
regulation of food intake and body weight in humans: a review. Obes Rev. 2007 
Jan;8(1):21-34. 
30. Hogenkamp PS, Mars M, Stafleu A, de Graaf C. Intake during repeated 
exposure to low- and high-energy-dense yogurts by different means of consumption. 
Am J Clin Nutr.  Apr;91(4):841-7. 
21 
 
31. Rolls BJ, Bell EA, Castellanos VH, Chow M, Pelkman CL, Thorwart ML. 
Energy density but not fat content of foods affected energy intake in lean and obese 
women. Am J Clin Nutr. 1999 May;69(5):863-71. 
32. Cox DN, Mela DJ. Determination of energy density of freely selected diets: 
methodological issues and implications. Int J Obes Relat Metab Disord. 2000 
Jan;24(1):49-54. 
33. Johansson L, Solvoll K, Bjorneboe GE, Drevon CA. Under- and overreporting 
of energy intake related to weight status and lifestyle in a nationwide sample. Am J 
Clin Nutr. 1998 Aug;68(2):266-74. 
34. Braam LA, Ocke MC, Bueno-de-Mesquita HB, Seidell JC. Determinants of 
obesity-related underreporting of energy intake. Am J Epidemiol. 1998 Jun 
1;147(11):1081-6. 
35. Park HA, Lee JS, Kuller LH. Underreporting of dietary intake by body mass 
index in premenopausal women participating in the Healthy Women Study. Nutr Res 
Pract. 2007 Fall;1(3):231-6. 
36. Vansant G, Hulens M. The assessment of dietary habits in obese women: 
influence of eating behavior patterns. Eat Disord. 2006 Mar-Apr;14(2):121-9. 
37. Kretsch MJ, Fong AK, Green MW. Behavioral and body size correlates of 
energy intake underreporting by obese and normal-weight women. J Am Diet Assoc. 
1999 Mar;99(3):300-6; quiz 7-8. 
38. Smith WT, Webb KL, Heywood PF. The implications of underreporting in 
dietary studies. Aust J Public Health. 1994 Sep;18(3):311-4. 
22 
 
39. King JA, Miyashita M, Wasse LK, Stensel DJ. Influence of prolonged 
treadmill running on appetite, energy intake and circulating concentrations of acylated 
ghrelin. Appetite. 2010 Jun;54(3):492-8. 
40. Lichtman SW, Pisarska K, Berman ER, Pestone M, Dowling H, Offenbacher 
E, et al. Discrepancy between self-reported and actual caloric intake and exercise in 
obese subjects. N Engl J Med. 1992 Dec 31;327(27):1893-8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.  Descriptives Characteristics of 
Participants 
  Mean ± SD 
n 78 females 
Age, years 18.8±0.9 
Height, cm 163.8±6.4 
Weight, kg 74.9±15.3 
BMI, kg/m2 27.9±5.5 
Waist circumference, cm 87.4±13.9 
Systolic BP, mmHg 106.5±9.7 
Diastolic BP, mmHg 66.6±7.8 
GLC, mg/dL 96.7±21.4 
Ghrelin, pg/dL 216.2±269.8 
Total energy, kcals 1731.9±507.1 
Total food weight, grams 2590.5±857.9 
fat, % kcals 30.8±6.7 
carbohydrates, % kcals 53.8±8.5 
protein, % kcals 15.1±3.6 
alcohol, % kcals  0.31±1.1 
IPAQ, MET-min/week 2,542.6±2107.5 
BMI = body mass index, BP = blood  pressure, TC = 
total cholesterol, HDL-C high density lipoprotein 
cholesterol, LDL-C= low density lipoprotein 
cholesterol, TAG = triglycerides, kcals = kilocalories,  
IPAQ = international physical activity questionnaire 
24 
 
 
 
  
Table 2. Descriptive Characteristics across Weight Status Groups 
  
Normal Weight 
(n=26) 
Overweight             
(n=26) 
      Obese    
      (n=26) 
  Mean SD Mean SD Mean SD 
Clinical 
Age, years 18.5 0.6 19.0 0.8 18.9 1.1 
Height, cm 164.4 1.5 164.1 5.2 162.8 6.9 
Weight, kg 59.0a 5.9 74.7b 7.4 90.8c 10.1 
BMI, kg/m2 21.7a 1.5 27.7b 1.6 34.2c 2.9 
WC, cm 72.7a 5.1 87.7b 6.6 101.7c 9.5 
Systolic BP, mmHg 103.7 7.0 106.8 10.8 109.0 10.5 
Diastolic BP, mmHg 65.6 5.7 67.1 8.8 67.2 8.8 
Biochemical 
      
GLC, mg/dL 85.4a 8.4 103.7b 26.6 101.1b 20.8 
Ghrelin, pg/mL 196.2a 78.8 217.1†a,b 106.6 150.1a,c 77.4 
Dietary             
Total energy, kcals 1968.0a 526.3 1707.9a,b 453.3 1519.8b 451.8 
Total energy, grams 2740.6 737.4 2513.2† 635.0 2369.7 828.5 
kcals fat, % 28.8 6.3 32.0 6.5 31.5† 7.1 
kcals carbohydrates, % 55.8 8.0 53.1 7.7 52.5 9.4 
kcals protein, % 14.7 3.1 14.8 3.6 15.9 3.9 
kcals alcohol, % 0.7 1.6 0.1 0.6 0.1 0.6 
IPAQ, MET-min/week 2672.6 1612.1 1999.1† 1199.5 2288.2† 1997.4 
†Removed 1 outlier, normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2) obese (>30 
kg/m2), data were determined using an ANOVA Note: different superscripts denote significant 
differences at p<0.05, BMI = body mass index, WC = waist circumference, BP = blood pressure, 
TC = total cholesterol, LDL-C = low density lipoprotein cholesterol, HDL-C = high density 
lipoprotein cholesterol, TAG = triglycerides, GLC = glucose, kcals = kilocalories, SD = standard 
deviation, IPAQ = International Physical Activity Questionnaire 
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Table 3. Total Daily Eating Time, Intake, Energy Density and Eating Rate 
  
Normal Weight  
(n=26) 
Overweight  
(n=26) 
Obese  
(n=26) 
All  
(n=78) 
Mean SD Mean SD Mean SD Mean SD 
Eating occasions (#/day) 4.1a 0.9 4.2a,b 1.1 3.4c 1.0 3.9 1.0 
Food intake (grams) 1631.6a 532.1 1371.5a,b 405.9 1257.3b 419.1 1420.1 476.8 
Eating time/day (seconds) 5398.4† 1828.1 6179.7† 2615.9 5727.2† 3171.9 6225.8 3445.9 
Energy intake (kcals) 1965.5a 528.0 1705.9a,b 457.5 1516.8b 453.8 1729.4 509.5 
Energy density (kcals/gram)  1.27 0.32 1.25 0.35 1.25 0.28 1.28 0.37 
Eating rate (grams/second) 0.28‡ 0.11 0.24 0.12 0.26† 0.17 0.29 0.21 
†removed 1 outlier, ‡removed 2 outliers, normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2), obese (>30 kg/m2), data was determined using 
ANOVA Note: different superscripts denote significant differences at p<0.05 
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Figure 1. Ghrelin concentrations According to Weight Status 
 normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2),   
obese (>30 kg/m2). Data were determined using ANOVA with Tukey’s  
follow-up Note: different superscripts denote significant differences at p<0.05 
kg = kilograms, pg = picograms 
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  Figure 2. Eating rate Correlated to Energy Density 
  Pearson correlation r=-0.385, p<0.01, kcals = kilograms 
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APPENDICES 
Appendix A: Review of Literature 
 
Introduction:   
Overweight and obesity are preventable causes of morbidity and mortality 
and affect over two-thirds of the American adult population1, 2.  Compared to lean 
individuals, overweight and obese individuals tend to have lower concentrations of 
the hunger hormone ghrelin, suggesting that weight status has a negative 
relationship with ghrelin3.  Eating rate and weight status are positively associated 
with energy intake4-6 and excess energy intake can lead to unhealthy weight gain.  
College females, ages 18 to 24, are a population of interest as they experience the 
greatest7-9 and most rapid10, 11 increase in overweight and obesity prevalence over 
the past 20 years.  A better understanding of how weight status impacts ghrelin and 
eating rate will help researchers determine how to intervene with these variables in 
regards to body weight regulation5, 12. 
 
Weight Gain Trends over the Lifecycle 
Unhealthy Weight Gain and Associated Health Risks 
Unhealthy weight gain is a concern during early childhood development, 
starting around age seven, as adult obesity13 and chronic disease risk factors 
originate during this period and continue to develop throughout life14.  Childhood 
obesity has nearly tripled in the past 30 years15 and the prevalence among 
adolescents aged 12-19 years has increased from 5% in 1980 to 18.1% in 20081, 16-
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18
.  These increases in obesity give rise to additional health risks factors in young 
adults for coronary heart disease (CHD) such as hypertension, dyslipidemia, 
impaired glucose tolerance, and vascular abnormalities which are already present 
in overweight adolescents19, 20.   Anthropometric measures such as elevated body 
mass index (BMI) (≥25.0 kg/m2) and increased waist circumference (>40 inches 
for men and >35 inches for women) predict individuals at risk for adult obesity 
and onset of CHD13, 21-23.   Guo et al.22 reported that the older and more overweight 
a child or young adult is, the higher the risk of being overweight or obese at age 
35.   
The increased number of overweight and obese young women (18-27 
years)11, 24, 25 is expected to increase female obesity in 2000 to 2020, from 34 to 
44%26.  This prevalence of obesity is expected to be seen in the college female 
population in particular compared to non-university females27.  Since increased 
BMI is positively associated with CHD risk; and more young adults are now obese 
than ever seen in previous decades, incidence of CHD and CHD related deaths are 
projected to occur more frequently in adulthood20, 26.  Berenson et al.28 conducted 
a longitudinal observational study of cardiovascular disease (CVD) risk factors 
from birth to 39 years in 204 males and females. There was an increased incidence 
of fatty streaks in coronary arteries from 50% at ages 2-15 to 85% (p=0.01) at ages 
21-39 and the amount of fatty streaks was positively correlated with BMI (r=0.48, 
p<0.05).  Preventing unhealthy weight gain during any life stage is critical in 
decreasing CHD risk but young adulthood is especially important as they are more 
likely to see increased unhealthy weight gain.  If obesity and its associated health 
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risks are not properly managed during childhood or adolescence they will only 
worsen, as the additional weight gain seen in those aged 18-29 years of age will 
exacerbate disease progression21.  Generally, young adults gain, on average, 
slightly less than one kilogram each year, the majority of this weight gain is seen 
during the early twenties29.  Preventing unhealthy weight gain and its associated 
health risks in this population will help decrease the prevalence of adverse health 
effects30. Exploring the college aged population in particular is critical as 
unhealthy weight gain is seen more often during this period of life. 
 
Transition to College and Unhealthy Weight Gain 
College students, traditionally between the ages of 18 and 24, are of  a 
population of interest as they experience the most rapid weight gain8.  Three out of 
ten college students are overweight (BMI 25-29.9 kg/m2) or obese ( BMI ≥30 
kg/m2) as indicated by the 2005 National College Health Assessment survey31.  
Freshman females entering college gain 2.2-9.2 pounds in the first 6 months to 
first year8, 29, 32 due to changes in dietary habits, physical activity or lifestyle 
alterations in making the transition from home to college33.  Unhealthy weight gain 
during college is of great concern and female college students gain more weight 
and gain it faster than their male counterparts34.   Therefore the college female 
population necessitates further exploration.   
Transitioning from high school to college is when many students 
experience a decrease in physical activity33 which can contribute to unhealthy 
weight gain.  However, research has mainly focused on dietary modifications for 
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effective weight loss35, 36.  With the limited evidence available in college students 
investigators feel it is the increased energy intake in conjunction with decreased 
physical activity that is responsible for weight gain in college students37.  In a 
longitudinal, observational study, Butler et al.33 reported weight gain (1.5±2.3 kg 
p=0.01), increase in BMI (23.6±3.9 kg/m2 vs. 23.9±3.9 kg/m2, p=0.01), increase in 
fat mass and percent body fat (32.0±14.4 pounds vs. 34.9±14.8 pounds, p=0.001 
and 22.0±5.7 vs. 23.8±5.4, p=0.001, respectively) and a decrease in fat-free mass 
(108.8±13.2 pounds vs. 107.5±12.6 pounds, p=0.01) from August to December in 
female college freshmen.   Wengreen et al.38 found 23% of participants gained 
≥5% of their body weight (4.52±1.61 kg, p<0.001) and 60.7% (p=0.05) of those 
participants engaged in less physical activity while in college compared  to high 
school38.   Another study, by Huang et al.25, reported that most overweight and 
obese college students did not meet the minimum goal of  ≥30 minutes of physical 
activity per day (aerobic and strength training) as recommended in the Surgeon 
General’s report on Physical Activity and Health39.   Decreased physical activity 
contributes to unhealthy weight gain in college along with various dietary factors. 
 
College and Unhealthy Weight Gain  
Excess energy intake and decreased physical activity contributes to 
unhealthy weight gain during college, as the environment is conducive to 
overconsumption of energy dense foods40-42.  Levitsky et al.41 reported 58% 
(p<0.05) of the total variance of weight gain from high school through the first few 
months of college was from increased energy intake.  Factors that contributed to 
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unhealthy weight gain include consuming breakfast, lunch and dinner at ‘all-you-
can-eat’ facilities (20% of total variance of weight change), high-fat food 
consumption (12% of total variance), evening snacking (12% of total variance) 
and increased “junk food” consumption (8% of total variance)41, 43.  Edmonds et 
al.10 reported a 2.4 kg increase with a concurrent BMI increase of 0.8 kg/m2 
(p<0.001) in young women making the transition from high school to freshman 
year of college.  In Vella-Zarb et al.’s44 meta-analysis of predictors of college 
freshman weight gain, there was a mean weight gain of 3.9±1.6 pounds and 
contributors were from recent dieting, increased energy intake, decreased physical 
activity and high psychological stress.   
 Anderson et al.32 measured weight status during freshman year of college 
and reported a mean weight gain of 1.7 kg (p<0.05) from September to May.  
Racette et al.45 examined weight changes from freshman to sophomore year of 
college and reported 70% of participants who were reassessed at the end of their 
sophomore year gained 4.1±3.6 kg (p<0.001).  Another study performed by 
Racette et al.8  reported the prevalence of overweight and obesity increased 23% 
(p<0.004) from freshman to senior year. 
In a quasi-experimental community-based comparison Hovell et al.27 found 
that females attending university gained a mean of 0.73 pounds/month, a rate that 
is 36 times faster than college-aged females not attending university (p<0.001) and 
university females were 2.6 to 5.2 times more likely to gain ≥15% above their 
initial ideal body weight.  Pliner et al.46 conducted a similar study and found 
women had a mean rate weight gain of 0.62 pound/month representing a total of 7 
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pounds in one year.  The factors contributing to unhealthy college weight gain 
need to be further explored for more effective weight gain prevention and weight 
regulation. 
 
Unhealthy Weight Status and CHD risk 
The importance of understanding the interrelations of weight, health risk 
and mortality is underscored by the increasing prevalence of obesity in the United 
States24, especially among women47.  Owen et al.48 examined the relationship 
between BMI before the age of 30 to CHD risk later in life and found that between 
18-30 years of age a one kgm-2 increase in BMI was positively associated with a 
8% increase in the risk of CHD (RR=1.08, 95% CI 1.05-1.11).  Similarly, Bibbins-
Domingo et al.49 determined the prevalence of adolescent overweight was 
projected to increase the prevalence of obesity among 35 year-old women from 
32.6 to 41.6%; and resulted in a 6% increase in overall CHD events leading to 
excess CHD deaths by age 35-65.  
 Kim et al.50 reported an 86% higher risk of developing CHD for females 
with a BMI in the highest quartile (≥27.61 kg/m2) compared to the lowest quartile 
(<22.34 kg/m2); and risk of death increased in the highest quartile (95% CI: 1.07, 
3.24).  Obesity is challenging to treat, especially in females51, therefore, prevention 
strategies are critical.  Exploring increased weight status in the young adult 
population may lend insight to prevent its co-morbidities, such as CHD, later in 
life52.  Another factor that may be associated with increased weight status is the 
appetite-stimulating hormone, known as ghrelin, as ghrelin shifts with changes in 
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weight and control appetite.  Focusing on ghrelin and its associations with body 
weight in the young adult population is important in regards to body weight 
regulation. 
 
 Ghrelin 
Ghrelin – an Orexigenic Hormone 
         Ghrelin, a 28 amino acid peptide constituted from a 117 amino acid 
human prepro-ghrelin chain53, was identified in 1999 as a hormone that may be 
involved in weight regulation by maintaining energy balance4, 54.  To date, ghrelin 
is the only peripheral hormone to display orexigenic, or appetite stimulating, 
effects through the hypothalamic appetite-regulating pathway, and has thus, has 
led to much research on its effects to enhance appetite and energy homeostasis4. 
 Ghrelin was discovered more than a decade ago, after the identification of 
its receptor, growth-hormone secretagogue receptor (GHS-R)55.  Growth-hormone 
secretagogues (GHSs) are small synthetic molecules that stimulate the release of 
growth hormone (GH) from the pituitary gland56.  These secretagogues work 
through a GHS-R, a G-protein-coupled receptor, for a ligand which was unknown 
at the time.  It was Kojima et al.56 who purified and identified the endogenous 
ligand specific to GHS-R, in the stomach of rats and called it ‘ghrelin’. 
 The name ghrelin is based on its role as a growth hormone-releasing 
peptide and comes from the proto-Indo-European word of ‘ghre’ which means 
grow57.  Ghrelin is primarily synthesized and secreted from the stomach mucosa, 
but is also secreted in other tissues such as the hypothalamus, pancreas, kidney, 
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and placenta58.  Ghrelin neurons have been identified in the pituitary gland, 
hypothalamic accurate nucleus (ARC), and in a group of neurons in the 
hypothalamic nuclei53.  There are two main molecular forms of ghrelin in humans, 
octanoylated ghrelin at position Ser3 on the amino acid chain and des-acyl 
ghrelin59.  The acylation of ghrelin occurs when the peptide undergoes a post-
translational modification in which the serine-3 position is covalently bonded to a 
medium-chain fatty by ghrelin O-acyltransferase (GOAT) enzyme, which converts 
ghrelin to its acylated or “active” form4, 60, 61.  The acylated form, which accounts 
for 20% of total circulating ghrelin, is said to be essential in the binding and 
activation of GHS-R1a, its classical receptor, as well as triggering GH secretion 
and appetite4.  Des-acyl (non-acylated, unacylated, des-acylated), ghrelin accounts 
for 80% of total circulating ghrelin and though it is unable to stimulate GH 
secretion, it may have other biological effects such as inhibiting cell proliferation 
on certain cancer cells and adipogenesis57, 62.  Total ghrelin is des-acyl and 
acylated ghrelin together63 and studies have looked at both total and acylated 
ghrelin response to food consumption and weight regulation68,69.    
 
Ghrelin and Short-Term Weight Regulation  
The importance of ghrelin in body weight regulation was strengthened by 
the finding that circulating ghrelin (total, acylated, des-acyl) concentrations are 
elevated  during fasting and decreased after food intake57.  Ghrelin was first 
administered to rodents which showed a rapid increase in food intake and body 
weight as well as stimulating their gastric motility and acid secretion64.  Ghrelin 
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administration in rodents also caused a decrease in fat oxidation and increased fat 
mass which resulted in increased weight gain65.  Tschöp et al.66 reported that 
ghrelin administration promoted food intake by stimulating hunger and conserving 
fat, resulting in increased body weight in mice and rats4.  Similarly, the effects of 
intravenous infusion of ghrelin administration on appetite and food intake have 
been reviewed in a human cross-over study67.  The orexigenic effects of ghrelin 
are short-lived (half-life is 8-11 minutes), as they require a signal to govern 
individual meals66.  This observation led to the belief that ghrelin may act as a 
physiologic meal initiator that takes part in short-term energy homeostasis by 
increasing hunger leading to significant increased food intake (average of 28% 
more calories)54.  Wren et al.67 investigated the effects of ghrelin administration on 
food intake indicating by weighing the food before and after meals and appetite 
sensations as measured by the visual analog scale (VAS) in non-obese males and 
females.  Participants reported an increase hunger rating of 16±10% (p<0.05) and 
an increase in energy intake by 28±3.9% (p<0.001) after ghrelin administration. 
 
Ghrelin and Long-Term Weight Regulation 
 Energy homeostasis is when energy intake equals energy expenditure68.  
Circulating ghrelin concentrations show compensatory responses to body weight 
change54, 69.  Ghrelin increases respiratory quotient (RQ) in rodents, suggesting 
reduced fat oxidation and increased glycolysis67, 70, 71, which favors fat deposition. 
Wren et al.67 saw no change in RQ in humans, however a trend towards reduced 
post-prandial energy expenditure was seen with ghrelin administration.  Weigle et 
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al.72 determined whether participants who lose weight on a low-fat diet experience 
the same increase in circulating ghrelin as those participants who lose weight on a 
low calorie diet.  Weight loss achieved on a low-fat diet failed to obtain a 
compensatory increase of 24-hour ghrelin profiles, as lipids were replaced with 
carbohydrates, which suppresses ghrelin better than lipids.  This suggests that 
macronutrient composition play a role in ghrelin regulation, and increased dietary 
lipids will offset the stimulatory effect of weight loss on ghrelin54, 73.   The effects 
of ghrelin on short- and long-term weight regulation may be important in the 
management and prevention of obesity. 
 
Ghrelin and Obesity 
Ghrelin may regulate body weight via a negative-feedback loop suggesting 
that concentrations should increase with weight loss and decrease with weight 
gain54.  Decreased ghrelin concentrations were reported in participants as a result 
of being in a constant positive energy state; therefore, obese individuals have 
lower fasting ghrelin concentrations than leaner individuals4, 66, 74, 75.  It is also 
possible that decreased plasma ghrelin concentrations represent a physiological 
adaption to the positive energy balance maintained in obese individuals3.   
However, in mice, an over expression of GHS-R does not affect energy intake 
response to GHS-R expression ligands76.  
Although research is unclear about the effects of ghrelin in obesity it is still 
a fundamental target as ghrelin is reduced in a positive energy state.  Wortley et 
al.77 studied the effects of ghrelin deficiency on growth, development, and 
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metabolic effects by placing ghrelin-deficient 6-week old mice on a high-fat diet 
for three weeks.  The ghrelin-deficient mice had less weight gain (30% lower body 
weight at 24 weeks, p<0.0001)77.  Zigman et al.78 compared 
intracerebroventricular ghrelin administration in wild-type mice versus GHS-R-
deficient mice, fed a high fat diet for 19 weeks.  Ghrelin did not stimulate food 
intake in GHS-R-deficient mice nor did it activate ARC neurons typically 
activated by ghrelin78.  After 8 weeks on the high-fat diet GHS-R deficient mice 
weighed significantly less than wild-type mice, and weight loss continued to 
progress such that after 19 weeks, GHS-R mice weighed 12.7% less than wild-
type, p<0.000178.  Both of these studies suggest that a lack of ghrelin secretion 
results in energy conservation and a down regulation of appetite stimulation in 
rodents.  Further research is warranted on the effects of appetite suppression as it 
relates to ghrelin in humans as obese individuals tend to have lower preprandial 
concentrations of ghrelin but postprandial ghrelin secretion is not sufficiently 
suppressed79.  
 
Ghrelin as a Potential Drug Target 
 Studies have started to investigate the potential therapeutic impacts of 
ghrelin on weight regulation and obesity4, 80.  Since ghrelin concentrations increase 
in obese individuals during weight loss, blocking ghrelin may prevent weight 
regain after weight loss53.  In addition, GHS-R antagonists may act as a potential 
drug target as they have high constitutive activity81.   Individuals feel hungry 
between meals, even though ghrelin concentrations have returned to their pre-meal 
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concentrations at this point.  If the constitutive activity of the receptor provides a 
signaling set-point, as suggested, in the stimulatory branch between meals, 
blocking the ghrelin receptor will result in lower food intake.  The set point 
blockage will increase the sensitivity to inhibitory signals, such as leptin, insulin 
and PYY3-36, and eliminate the craving for hunger81.  Even with all the potential of 
using therapeutic drugs to treat obesity, researchers still feel medications need to 
be in combination with diet and physical activity modifications53.    
 
Ghrelin and Macronutrients 
 Gastric ghrelin expression is dependent on feeding state and macronutrient 
composition in the diet82.  Ghrelin expression decreases more after a carbohydrate-
rich compared with fat-rich meal83.  Some studies suggest a possible interaction 
between the gastric chemosensory system, which shares signaling mechanisms 
with gastric organs84, and ghrelin regulation85, 86 but inconclusive data exists.  
Others have stated ghrelin is regulated post-absorption into the blood and not 
related to gastrointestinal sensing87.  Al Massadi et al.85 investigated the direct 
effect of the three macronutrients in the forms of l-glutamine (protein), intralipid 
(fat), and glucose (carbohydrate) over gastric ghrelin secretion in vitro in a rat 
gastric explants model.  Carbohydrates had a stronger inhibitory effect than fat on 
gastric and circulating ghrelin concentrations, and ghrelin secretion decreased with 
l-glutamine perfusion.  They postulated, though a post-gastric mechanism 
mediating action of macronutrients on ghrelin should not be ruled out, amino acids 
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and lipids act directly on gastric ghrelin-producing cells in order to regulate 
ghrelin release85.  
 Ghrelin suppression is diminished in obese, insulin-resistant participants, 
therefore, post-prandial ghrelin suppression may contribute to increased intake and 
obesity88.  Yang et al.88 compared fasting and postprandial concentrations of 
ghrelin after meals with various macronutrient contents and how the macronutrient 
composition may contribute to obesity by affecting appetite and food intake.  
There was less ghrelin suppression in obese than lean individuals 30 minutes after 
each meal.  There was also less ghrelin suppression after the high fat meal than the 
high carbohydrate meal.   Decreased ghrelin secretion in obese participants is 
related to decreased satiation and overconsumption.  The physiological 
mechanisms that modulate plasma ghrelin are not well understand, it has been 
shown that insulin can suppress ghrelin and glucose can regulate ghrelin 
independently of insulin89.  In the Yang et al.88 study there was an inverse 
association between postprandial ghrelin and insulin concentrations in lean but not 
obese participants. 
 
Ghrelin and Insulin 
 Ghrelin concentrations show a diurnal variation and may be influenced by 
age, gender, BMI, GH, leptin, glucose and insulin53, 64, 90, however, the 
relationships between these variables are unclear91.  McCowen et al.92 studied the 
effects of glucose and insulin infusion on ghrelin concentrations in mice and 
concluded ghrelin concentrations were reduced (p<0.01) with infusion of glucose 
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and insulin (85±2 and 103±0.6pM) versus the control (saline) infusion (163±9 
pM).  This suggests that ghrelin is strongly regulated by the rise insulin after a 
meal, which activates satiety signals of the hypothalamus.  Some studies found 
ghrelin administration to be associated with a reduction in insulin secretion93, 94, 
while other studies exhibited insulin infusion suppressing ghrelin concentrations95.  
The mechanisms for this regulation in rodent’s insulin receptors in the intestine 
retain signaling function, though regulation in humans remains unclear96.   It is 
suspected that in humans, insulin activates neural circuits that influence ghrelin 
release.  Ghrelin stimulates glucagon secretion from isolated mouse pancreatic 
islets97, so ghrelin likely blocks the inhibitory effect of insulin on gluconeogenesis 
demonstrated in hepatoma cells98.  These findings suggest that ghrelin may be 
involved in the regulation of glucose metabolism via down-regulating insulin 
secretion and glucose consumption99.    
 
Figure 1 shows how ghrelin signals insulin release from pancreatic β-cells.  
The ATP-sensitive K+ (KATP) channels are closed by increases in the ATP/ADP 
ratio following glucose metabolism; this induces membrane depolarization and an 
Figure 1. Ghrelin signaling, Dezaki et al. 
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increase in cytosolic Ca2+ channels.  This increase leads to insulin secretion by the 
β-cells.  Ghrelin activates the β-cell GHS-R that is coupled with the G-protein Gαi2 
which activates K+ channels and consequently suppresses Ca2+ channels influx and 
suppresses insulin release. 
Ghrelin concentrations are negatively associated with insulin resistance in 
humans100, suggesting a pathophysiological role of ghrelin in the regulation of 
insulin release101.  Ghrelin in obese individuals could be involved in energy and 
glucose metabolism in which insulin plays an important role.   However, under 
conditions when the demand of insulin exceeds its production, such as individuals 
with insulin resistance, ghrelin can promote insulin secretion and prevent glucose 
intolerance.  The function of ghrelin in regulating glucose metabolism, paired with 
GH release and feeding, supports that ghrelin may play an integrative role in 
regulation of energy homeostasis101.   
Ghrelin and Leptin 
 The stimulatory effect of ghrelin on food intake has raised questions on its 
interaction with other appetite-related molecules, such as leptin.  Leptin is an 
adipose tissue-derived hormone secreted in proportion to body fat which plays a 
crucial role in body weight regulation102, 103.  Receptors for leptin are expressed by 
hypothalamic neurons103, such as those in the ARC, which are involved in energy 
balance. Leptin administration directly into the brain results in a decreased food 
intake and appetite103, 104.   Leptin reduces hypothalamic NPY mRNA expression 
which is reversed by action of ghrelin105, 106.  A competitive interaction between 
ghrelin and leptin is shown in in vitro calmodulin-dependent protein kinases (Ca2+) 
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signaling studies, where leptin inhibits a ghrelin-induced increase in Ca2+ in about 
70% of the ARC neurons.   
Leptin also significantly decreases ghrelin mRNA expression in both obese 
and lean mice, suggesting a downstream in gastric ghrelin by leptin107.  However, 
in one study chronic administration of leptin increased ghrelin mRNA expression 
in the stomach as well as decreased food intake and body weight103, 108.  Gastric 
ghrelin might reflect physiological changes with altered food intake rather in the 
presence of leptin.   Though administration of ghrelin failed to modify 
concentrations of leptin, the interactions of these two hormones at the present time 
need to be further reviewed.  It is also not clear whether abnormalities in these two 
hormone systems contribute to the development of obesity.  Nevertheless, 
disturbances in their regulatory systems seems to play some sort of a role in the 
maintenance of obesity53. 
 
Figure 2 displays a simplified depiction of the appetite regulatory roles of 
leptin and ghrelin.  Leptin acts as part of a feedback loop to maintain consistent fat 
Figure 2. Action of ghrelin and leptin on feeding-regulatory system.  Inui et al. 
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stores and reduces food intake by two hypothalamic pathways, both originating in 
the ARC and lateral hypothalamic area 109.  Ghrelin abruptly releases from the 
stomach, 20-30 minutes before a meal81, and has the opposite effect on the 
hypothalamus by stimulating an anabolic state and secretion of GH by acting on 
the anterior pituitary gland.  Fasting decreases leptin and increases ghrelin, leading 
to an activation of the orexigenic ghrelin pathway103. 
 
Ghrelin and Energy Balance  
The effects of ghrelin on energy balance are largely regulated through the 
hypothalamus, which is involved in feeding behavior regulation110.  Korbonits et 
al.111 hypothesized three pathways for ghrelin’s satiating affects.  First ghrelin may 
cross the blood brain barrier and bind to its receptors in the hypothalamus.   
Second, ghrelin will reach the brain through the vagal nerve112, 113, and third, 
ghrelin is produced in the hypothalamus, where it may directly affect the local 
nuclei111.  Both central and peripheral administration of ghrelin in rats stimulates 
food intake through the activation of hypothalamic NPY/Y1 receptor pathway and 
the resulting antagonizing leptin action106.  Nakazato et al.106 demonstrated 
decreased food intake after intracerebroventricular injection of ghrelin antiserum 
in rats, which further demonstrates ghrelin’s biological role in energy balance. 
Furthermore, obese individuals who lose even 5% of their body weight 
significantly increase circulating ghrelin concentrations54.  Cummings et al.114 
found mean area under the ghrelin curve increased 24% (9,635±1127 pgs-day/ml 
to 11,585±1449 pgs-day/ml, p=0.006) with a mean weight loss of 17.4±1.5% 
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(p<0.001) of initial body weight.  Similarly, Hansen et al.91 noted baseline fasting 
ghrelin in obese individuals increased 12% (114±17 fmol/ml vs. 128±16 fmol/ml, 
p<0.01) following a six month weight loss course.  Fasting ghrelin was positively 
correlated with the extent of participant weight loss (r=0.68, p<0.05).  The theory 
that ghrelin is involved in long-term weight regulation is supported by the fact that 
ghrelin concentrations adapt to changes in weight status54.   
Furthermore, the number of calories in a meal is related to the depth and 
duration of postprandial plasma ghrelin suppression in a dose-dependent manner 
when all other characteristics of a meal are held constant115, 116.  This suggests that 
consuming larger meals suppresses ghrelin and hunger more substantially than 
smaller meals.  The magnitude of pre-prandial recovery of ghrelin concentrations 
correlates with the number of calories consumed in the following meal117.  
Research shows polymorphisms in the GSH-R gene are associated with alterations 
in eating patterns consistent with the belief that ghrelin may be a determinant for 
meal time118.   A more complete understanding of ghrelin’s role in energy 
homeostasis will help promote healthy weight loss by achieving a more negative 
energy balance. 
 
Ghrelin and Energy Expenditure 
Another area of research that is gaining momentum is the effect of exercise 
on ghrelin and energy balance.  In rodent studies, ghrelin administration resulted in 
increased RQ66, 67.   The role of ghrelin in the regulation of energy homeostasis in 
humans, however, is less clear.   Some studies noted the metabolic effects may 
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extend beyond the regulation of appetite and satiety and potentially serve as a 
biomarker of increased energy efficiency, meaning lower energy expenditure, in 
humans119.   
St-Pierre et al.119 investigated the relationship between ghrelin and energy 
expenditure with resting metabolic rate (RMR) and thermic effect of food (TEF) in 
young women.  They reported the negative correlation between ghrelin 
concentrations and RMR (r = -0.350, p=0.004) and TEF (r = -0.396, p=0.001) 
were independent of body composition.  Marzullo et al.120 explored the 
relationship between active and total ghrelin and resting energy expenditure and 
reported obese individuals with a positive energy expenditure ratio 
(measured/predicted energy expenditure) had higher concentrations of active 
ghrelin (214±22 vs. 159±30 pg/ml pmol/liter, p<0.05) than individuals with 
negative ratio values (106±2 vs. 97±1; p<0.01)120.  Huda et al.121 examined the 
effects of ghrelin on appetite and energy expenditure in three participant groups: 
lean, obese and post-gasterectomy.  They reported that lean subjects postprandial 
RQ rose after ghrelin infusion but the rise was not significant (0.92±0.03 vs. 
0.97±0.03, p=0.13).  In contrast, obese individuals had no significant postprandial 
rise in RQ during the saline infusion (p=0.1) but did during the ghrelin infusion 
(0.86±0.01 vs. 0.93±0.03, p=0.03).  However, there was a significant effect of 
ghrelin on displacement from baseline values compared with the saline infusion 
(f(8,168)=6.2, p<0.001) suggesting that peripheral ghrelin increased RQ variability 
in all three groups over time.  Exploring the effects of weight status on ghrelin 
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concentrations more closely and paired with eating patterns and eating rate may 
benefit this unclear area of research. 
 
 CIII. Eating Rate 
What is Eating Rate? 
Though there is no widely accepted operational definition or validated 
objective measurement of eating rate, it can be defined as the amount of time it 
takes to consume a meal or snack.  Eating rate has been measured in various ways 
including: grams/minute, kilocalories/minute, grams/second, bites/minute and 
number of bites/second122-125.  It is analyzed as a categorical and continuous 
variable.  Eating rate may affect energy intake since a slower eating rate enhances 
satiety by allowing gastrointestinal peptides to register meal termination and 
prolong pleasurable aspects of eating6.  This was first investigated by Spiegel et 
al.126 who manipulated ingestion rates of a liquid diet during oral and gastric 
feedings and found eating rate was positively correlated with amount of food 
intake.  Lean and obese individuals have different eating behavior microstructures, 
known as the basic reflexive units of general intake such as licks, chews, and 
swallows127.  These different behaviors have led researchers to focus on eating 
behavior and weight status in order to understand its role in body weight 
regulation128, 129.    
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Eating Rate and Obesity 
In 1962, Ferster et al.130 first introduced the idea that obese individuals eat 
faster than lean; since then eating behaviors, particularly eating rate, gained 
importance as contributing factors in the progression of obesity131.  Though eating 
behavior has been examined in naturalistic and laboratory settings,  results are 
conflicting if obese individuals are faster eaters than lean individuals132.  
Teitelbaum and Campbell133 examined eating behaviors during a liquid and solid 
diet in obese hyperphagic, nonobese hyperphagic and control female rats and the 
obese hyperphagic rats ate more than normal controls when consuming the liquid 
diet (45.3 mL vs. 42.7 mL) and ate faster when consuming the solid diet (5.1±0.85 
vs. 4.0±1.1 pellets/minute).  The increased food consumption of the hyperphagic 
rats is closely related to how obese they are meaning that these rats will overeat 
which indicates investigation on the relation of obesity and food intake. 
It is unknown whether or not eating rate is an acquired eating behavior.  An 
individual with a rapid eating rate during childhood may continue to eat rapidly as 
an adult134.  Otsuka et al.131 examined the association between self-reported eating 
rate and BMI as well as BMI-change from age 20 to current age (48.2±7.1 years).  
Female BMI was positively associated with self-reported eating rate (from very 
slow -1.06, relatively slow -0.35, relatively fast 0.81, and very fast 1.47 kg/m2).  
Research also shows obese individuals take larger and faster bites than lean 
individuals135, possibly contributing to overconsumption and increased body 
weight.  Gaul et al.122 looked at eating rates in obese and non-obese participants 
during a 5-minute observational meal and reported obese participants took more 
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bites, chews/bite and spent less time chewing than non-obese (16.94 vs. 12.66, 
9.24 vs. 18.6, respectively).  Female obese participants took more bites than non-
obese (16.8±3.3 vs. 12.3±2.5 bites, p<0.01) and spent less time chewing 
(104.1±35.4 vs. 153.5±33.9 seconds, p<0.01).  Similarly, Hill et al.123 reported that 
obese male participants consumed more grams per second than non-obese during a 
dinner meal (0.95 vs. 0.73, p<0.05), partially due to slightly larger bites (7.2 vs. 
6.2 grams/bite) and faster chewing or less chewing per bite (7.9 vs. 8.7 
seconds/bite).  Another study performed by Hill et al.136 reported that as weight 
status increased bite size (7.1±2.3 vs. 6.3±2.0) and eating rate (0.4±0.2 vs. 0.4±0.1) 
increased, resulting in a faster eating time (286.2±108.8 vs. 329.2±133.8 seconds).  
Women took more bites (20.7±6.6 vs. 15.8±10.4, p<0.05), more time to eat 
(352.8±121.7 vs. 290.7±128.3, p<0.05) and ate fewer grams per second (0.3±0.1 
vs. 0.4±0.2, p<0.05) than men.  Eating rate and energy intake are mostly measured 
in a controlled lab setting, but research examining these variables in a more 
naturalistic setting is limited. 
 
Obesity and Underreporting of Energy Intake 
 Underreporting of dietary intake is a frequent challenge in nutrition 
research when using self-reported dietary assessment methods137.  Goldberg et 
al.138 suggested that reported energy intake (EI) can be used to evaluate reported 
EI against presumed energy requirement.  Energy intake is expressed as multiples 
of estimated basal metabolic rate (BMR), and the ratio of EI/BMR; indicates 
energy reporting status. Obesity has been the common denominator with low 
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EI:BMR ratios, as a reported risk factor for underreporting137.  Obese individuals 
underreport their dietary intake by 20-50%139 but little is known about how it can 
be prevented140.  According to the 1994 National Health and Nutrition 
Examination Survey, females141, 142, as well as adults with a BMI greater than 
27.3kg/m2 underreport energy intake more than adults with a lower BMI143.   
 Johansson et al.144 found that underreporting of EI is more common in 
younger individuals (16-29 years, p<0.001) compared to older individuals.  
Percentages of overreporting were larger in males than females (15% compared to 
29%)144.  Females that were underreported according to (EI:BMR of <1.14) 
accounted for 25% of the female sample; of these about 46% had a BMI of 25-
35kg/m2. Braam et al.142 also explored what predicts dietary underreporting and 
found each increase in BMI by 1 kg/m2 was associated with a decrease in energy 
ratio in women (β= -0.0262).  Age was also another independent determinant of 
underreporting, with energy ratios being the lowest among men and women older 
than 40 years. These studies suggest that the degree of obesity will influence 
dietary reporting quantitatively and qualitatively.  
 
Eating Rate and Energy Intake 
Duncan et al.145 examined the effects of high energy density (HED) and 
low energy density (LED) diets on energy intake, satiety and eating time in obese 
and non-obese individuals.  They speculated that longer meal duration and 
mastication time on a LED diet and eating to the point of comfortable versus an 
uncomfortable point on a HED diet, resulted in a lower energy intake (LED 
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1,570±290 kcal/day vs. HED 3,000±460 kcal/day, p<0.01)145.   Similarly, Andrade 
et al.124 reported that eaters in the slow with-in meal eating condition consumed 
less energy compared to eaters in the quick condition (579.0±154.7 kcal vs. 
645.7±155.9 kcal; p<0.05); but satiety for eaters in the quick condition remained 
lower at meal completion.  Small bite sizes and pausing between bites resulting in 
a slower eating rate was shown to decrease the rate of ingestion, enhance satiety 
and energy intake.  Eating slower may leave more time to consume water, creating 
distention, satiety and decreased energy intake; such as in this study as more water 
was consumed under the slow condition124.  Sasaki et al.5 reported a positive 
association between body weight, BMI and eating rate.  Energy intake also 
increased with increased eating rate (8,304 kJ/day vs. 7,286 kJ/day, p<0.001). 
 
CIV. Ghrelin and Eating Rate 
Current Research on Ghrelin and Eating Rate 
Though ghrelin and eating rate have received more attention recently, few 
studies have examined the effects these two variables together. Both, eating rate 
and ghrelin impact energy homeostasis which is positively related to weight status.  
Postprandial concentrations of ghrelin and other appetite-related hormones have 
minimally been examined in the context of different eating rates146, 147.  However, 
the mechanisms between these two variables are unclear and warrant further 
research. 
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Eating Rate and Ghrelin 
Zijlstra et al.148 reported desacyl ghrelin concentrations were higher after 
consumption of a semi-solid meal (p=0.004), and observed a greater and more 
prolonged reduction of total ghrelin after the solid meal.  Sobki et al.146 reported 
participants with a slow eating speed had persistent elevations in ghrelin 
concentrations (887.2±21.9 pg/ml vs. 827.5±16.5 pg/ml, p<0.01) compared to 
those with normal eating speed.   Ghrelin concentrations were elevated at fasting, 
decreased after meal initiation and rose during the late postprandial period, 
suggesting that ghrelin is a signal for meal initiation and concentrations rise more 
steadily while eating at a normal pace.  However, Kokkinos et al.147 reported no 
difference in ghrelin area under the curve values after a 5 minute versus a 30 
minute meal (29,133.1±11,392.1 pmol/liter ·  min vs. 136,304.2±12,619.6 
pmol/liter ·  min, p=0.3), though there was a trend for lower ghrelin at the 120 
minute time point for the 30 minute meal duration.  These results suggest that 
eating rate may not influence orexigenic ghrelin, as much as anorexigenic 
hormones.  The inconsistent findings between eating rate and ghrelin 
concentrations are the reason for more research, especially when comparing to 
different weight status categories.  Future studies are needed to explore the 
associations between ghrelin and eating rate to help reverse this universal trend 
towards increased weight gain in young adults and reduce the risk of health 
complications later on in life. 
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CV. Eating Rate and Energy Density 
Energy Density  
The roles that eating rate and energy density play in weight status have not 
been thoroughly investigated.  A variable known to influence weight status and 
short-term energy intake is energy density (kilocalories/gram)149.  Therefore, it 
may play a role in the control of energy balance as it influences food and energy 
intake150.   It is recommended that following a LED diet, which provides fewer 
calories per gram, is preferred for weight management.  Individuals consume more 
energy when presented with foods with a higher energy density compared with 
similar foods having a lower energy density149, 151-153.  Research examining the 
relationship between energy density and weight status in free-living individuals is 
difficult to interpret and hard to compare in part to methodological differences.   
 
Methods of Calculating Energy Density 
Little is known about energy density in free-living individuals, dietary 
analysis programs do not automatically calculate energy density nor is there a 
standard calculation149.  Many methodologies have been proposed; usually foods 
only150, 154-156, but others vary with inclusion beverages150, 157, 158.  The primary 
controversy surrounds beverages, which tend to have a lower energy density than 
foods and can disproportionately influence energy density values149, 150.   Energy 
density values vary between 1.36 kcal/g and 1.82 kcal/g depending on the method 
used.   
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Ledikwe et al.149 examined eight calculations of energy density (food only; 
food and liquid meal replacements; food and alcohol; food and juice; food and 
milk; food, juice, and milk; food and energy-containing beverages; and food and 
all beverages excluding water).  The method of food only or food and liquid meal 
replacements had the highest value (1.85 kcal/g) and the all food and beverages 
method had the lowest value (0.94 kcal/g).  There was a significant inverse linear 
trend for age with energy density values: the youngest group 20-29 year olds (2.02 
kcal/g) and the oldest group ≥70 years (1.61 kcal/g).  A few conclusions could be 
drawn from this study regarding the variations in energy density calculations, the 
first is if beverages are included in the calculation they need to be clearly defined.  
Second, energy density values may not provide meaningful measures in food and 
all beverages excluding water methods, because individuals who drink a lot of 
water will have a higher energy density values..     
Cox et al.150 examined six different methods of energy density (all foods 
and all beverages; all foods and all energy-containing beverages; food and all 
milk; food only; all dry matter; and protein, carbohydrate, fat only) and their 
implications for differences in lean and obese participants as well as examining 
relationships between energy density and macronutrient intake.  Obese participants 
reported a greater energy density intake compared to lean individuals under the 
food and all milk method, however the opposite result was found under the all dry 
matter method.   These results have been seen in similar studies, the energy density 
values varied with the inclusion and exclusion of different beverages.  Another 
implication with the concern of using different calculations was the lack of 
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significant correlations seen between five of the six methods related to dietary fat 
for the obese group.  In contrast, the macronutrient only method had a high 
significant correlation was found with the percentage of dietary energy from fat 
(r=0.56, p<0.0001)150.  The conclusions drawn from energy density studies have 
shown there is no one method better for calculating than another.  The results are 
widely different and interpretations are highly variable and hard to compare 
between different studies.  Future researchers must carefully define energy density 
methods to better understand their variability and how they may relate to energy 
intake and weight status. 
 
Energy Density, Energy Intake and Eating Rate 
 Consuming a HED diet results in increased energy intake153, 159, 160, but 
whether the energy density of diet affects an individual’s eating rate unclear. 
Duncan et al.145 compared the effects of low and high energy dense diets on satiety 
and rate of energy intake in obese and nonobese participants.  Eating time 
averaged 17 minutes or 33% longer per day on the low energy dense diet than the 
high energy dense diet (69±14 versus 52±11 min/day, p=0.0001) and there was no 
significant differences between obese and nonobese groups (60±17 versus 61±13 
min/day, respectively).  However, rate of energy intake on the LED diet was about 
one third (39%) that of the HED (23±3 kcal/min versus 59±9 kcal/min, p=0.0001).  
The prolonged eating time on the low energy dense diet might be in part to the 
sensation of satiety at a low energy intake145.  Hogenkamp et al.161 compared 
consumption time and eating rate with 3 groups (liquid/straw, liquid/spoon, and 
57 
 
semisolid/spoon) of yogurts offered at a LED and HED.  Eating rate (intake in 
grams/min) was higher in the liquid/straw group (132±83g/min) than in the spoon 
groups (liquid/spoon: 106±53g/min, semisolid/spoon: 105±88g/min, p=0.01).  
Individuals ate more under the LED diet occasion for the semisolid meal 
(486±246g versus 458±204g p=0.002).  Though energy intake was lower under the 
LED yogurt; it was eaten at a quicker rate.  Therefore, energy intake of a meal may 
be dependent on the energy density of the foods available at a meal161.  Exploring 
energy density and energy intake in populations exposed to a variety of high 
energy dense foods may be a crucial step in weight management.  
 
Energy Density and College Students 
Many research studies have identified college students as a population with 
poor and inconsistent compliance to healthy diet practices and nutrient dense 
foods40, 162, 163.  Anding et al.163 reported that two-thirds (66%) of the female 
participants exceeded recommended levels of saturated fat and 20% exceeded 
cholesterol recommendations.  Approximately 43% of the women complied to at 
least one dietary guideline recommendation, 32% adhered to at least two 
guidelines, but none followed all seven guidelines studied163.  This suggests that 
college females are not aware of the dietary guidelines or they are exposed, in the 
college environment, to higher fat and energy dense foods.   Melby et al.164 
observed a random sample of students from a large university to assess dietary-
related behaviors, knowledge and beliefs.  The majority of students had an 
understanding of basic nutrition concepts, but 69% failed to consume fruit once a 
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day and 43% indicated they ate one vegetable less than once per day.  There is a 
significant percentage of college students have unfavorable dietary habits, more 
research is needed to determine exactly what factors contribute to these habits.  
Strong et al.40 sought to identify health behavior changes related to weight 
management in college students and reported students generally skipped breakfast, 
snacked on chips or sweets, consumed water, juice, sweetened beverages and 
when on short time (≥1-3 times per week) consumed fast foods.  College students 
are introduced to a variety of energy dense foods and adapt new dietary patterns, 
the decline of healthful meals and snacks as part of a routine decreases from high 
school to college.  It is important for health care professionals and researchers to 
identify the causes of these changes when working with the young adult college 
population and consider energy dense foods as a contributing factor. 
 
CVI. Conclusion 
 Overweight and obesity are preventable causes of morbidity and mortality 
and affect over two-thirds of the American adult population 1, 2.  Obesity is 
positively correlated with increased risk of chronic diseases, the most prevalent 
being CHD-related deaths20, 48, 49.  The increased number of overweight and obese 
young women (18-27 years)11, 24, 25 is expected to increase from 34 to 44% 
between 2000 and 2020, 26.  The prevalence of obesity is seen more in the college 
female population compared to non-university females27.  The factors contributing 
to unhealthy college weight gain need further exploration for more effective body 
weight regulation. 
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Both eating rate and ghrelin influence energy homeostasis125, 165-167, which 
is positively associated with weight status.  Research shows obese individuals take 
larger and faster bites than lean individuals135, which may possibly contribute to 
overconsumption and increased body weight.  Circulating ghrelin concentrations 
show compensatory responses to body weight change54, 69, suggesting it plays a 
role in long-term weight regulation.  Postprandial concentrations of ghrelin and 
other appetite-related hormones are minimally examined in the context of different 
eating rates146, 147, and the mechanisms between eating rate and ghrelin are unclear 
and warrant further research. 
Energy density and eating rate play a role in weight status and the control 
of energy balance by influencing food and energy intake150.   Research examining 
the relationship between energy density and weight status is crucial because 
individuals consume more energy when presented with high energy dense foods 
compared to a low149, 151-153.  Excess energy intake contributes to unhealthy weight 
gain during college, as the environment is conducive to overconsumption of 
energy dense foods40-42.   
It is important to determine the relationship between weight status, eating 
rate and ghrelin concentrations in order to maintain a healthy body weight and 
energy homeostasis.  Though some factors are clear on the effects of weight status, 
ghrelin, eating rate, and energy intake individually, there is limited research 
focusing on the relationships among these variables.  Once a better understanding 
is established, researchers and healthcare professionals can provide insight on the 
beneficial effects to improve individuals’ overall quality of life.  
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Appendix B: Extended Materials and Methods 
METHODOLOGY: 
Research Design 
 This research is an ancillary study examining the effect of weight status on 
ghrelin concentrations and eating rate.  It will also look for a relationship between 
eating rate and energy density of a meal consumed. Cross-sectional data from the 
Best Foot Forward Study (BFF) and the Nutrition Assessment and Chronic 
Disease Risk Factor Identification (Hatch) study will be used.   The BFF study was 
a randomized clinical trial and examined the effectiveness of a self-taught 
intervention versus an instructed intervention on coronary heart disease (CHD) 
risk factors in overweight and obese female students at the University of Rhode 
Island (URI) over eight weeks.  However, in the present study only baseline data 
will used for analysis.  The Hatch study was cross-sectional and determined the 
prevalence of metabolic syndrome and CHD risk factors and their relationship to 
dietary intake and physical activity in first year URI students. 
 
Subjects 
All BFF and Hatch participants read and signed informed consents for their 
respective studies, which were approved by URI’s Institutional Review Board.  
Participants for both studies were recruited via flyers posted around campus and in 
dormitories, through “The Good 5 Cent Cigar” advertisements, presentations made 
in classes, and informational booths at Hope dining hall and the Memorial Union 
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Building on URI’s Kingston campus.  Eligibility criteria for each study is outline 
in  
 
Table 1.  
Table 1.  Eligibility Criteria for the Hatch and BFF Studies 
Hatch Study BFF Study 
First year URI student  Female URI student 
No body mass index (BMI) parameters BMI 25-39.9 kg/m2 
Between the ages of 18 and 24 years Between the ages of 18 and 24 years 
Not pregnant or lactating Not pregnant or lactating 
No diagnosis of: CHD, diabetes mellitus 
(DM), liver disease, cancer, bleeding 
disorder 
No diagnosis of: CHD, DM, liver 
disease, kidney disease, cancer, 
bleeding disorder 
Not on any lipid-lowering medications Not on any lipid-lowering medications 
No history of an eating disorder No history of an eating disorder 
 
Seventy-three participants signed informed consents for the BFF study, 9 
were unwilling or unable to complete the study, leaving a final sample size of 64.  
Participants were recruited in two cohorts, spring and fall of 2009.  The BFF 
participants had a mean BMI of 29.7±3.63 kg/m2 and consisted of ~64% 
participants who were overweight (n=41) and ~36% who were obese (n=23).  
Sixty-seven percent of the participants identified themselves as Caucasian (n=43), 
16% Black/African American (n=10), 8% Hispanic (n=5), and 9% as other (n=6).   
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Two-hundred-and-ninety-four participants signed informed consents for 
the Hatch study, 33 were unwilling or unable to complete the study, leaving a final 
sample size of 261, 67% females (n=176) and 33% males (n=85).  Reasons for 
attrition included lack of time, illness, and lack of response to study contacts.  The 
Hatch participants were recruited in four cohorts, spring and fall of 2008 and 
spring and fall of 2009.  The Hatch female participants had a mean BMI of 
22.9±3.84 and consisted of 4.5% underweight participants (n=8), 77.3% normal 
(n=136), 13.1% overweight (n=23) and 5.1% obese (n=9).  Of the female sample 
82% identified them as Caucasian (n=144), 3.4% as Asian (n=6), 3.9% as African 
American (n=7), 0.5% as American Indian (n=1) and 10.2% as other (n=18).   
Baseline Measurements  
Anthropometric 
For both studies, all anthropometric measurements were performed in 
duplicate to assure that measurements were within 0.2 cm for height and 0.1 kg for 
weight (1).  Height was measured using a 220 stadiometer (Seca Corporation, 
Hamburg, Germany).  Waist circumference was measured using Gulick non-
stretchable tape with an attached tensometer at the top of the iliac crest upon 
exhalation (Patterson Medical, Mouth Joy, PA) while participants were in a 
standing position (1).  In the Hatch study, weight was measured using a calibrated 
digital Seca 769 scale (Seca Corporation, Hamburg, Germany) to the nearest 0.2 
kg; for the BFF study, weight was measured to the nearest 0.1 kg by using a 
calibrated digital read scale (Bod Pod, Version 2.14, Body Composition System; 
Life Measurement Instruments, Concord, CA). Both studies used height and 
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weight to calculate participant BMI (weight in kilograms/height in meters2).  The 
participants will be broken up into three categories based on their weight status: 
normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2) and obese (≥30 
kg/m2) (2, 3). 
Biochemical 
For both studies, a trained phlebotomist conducted two 12-hour fasted 
venous blood draws on two nonconsecutive morning visits in the same week.  
Samples were processed according to a previously described protocol (4).  Briefly, 
plasma was obtained from whole blood via centrifugation (Eppendorf Centrifuge 
5810, Germany) for 20 minutes at 2200 RPM’s at 4oC. The following preservation 
cocktail was added to the plasma samples: 0.01g/100g of phenylmethyl sulfonyl 
fluoride (Roche, Indianapolis, IN), 0.01g/100g of sodium azide (Fisher, Fairlawn, 
NJ) and 0.05g/100g of aprotinin (Fisher, Fairlawn, NJ) and were stored at -80° 
until analyses.   
Enzymatic assays for analyses were performed for glucose (GLC) 
concentrations using a Wako Glucose Autokit (Wako Diagnostics, Richmond, VA) 
(5).   
Clinical 
 Resting blood pressure (BP) was measured by a trained exercise 
physiologist after a five-minute seated rested period using a stethoscope (Littman, 
St. Paul, MN) an appropriately sized BP cuff (Fisher Scientific, Fairlawn, NJ and 
Welch-Allyn, Skaneateles Falls, NY).  Blood pressure was measured in duplicate 
unless variance between measures exceeded the standard (two mmHg), in which 
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case the measurement was repeated.  The average of the two readings within the 
standard was used for data analysis. 
Physical Activity 
Both studies assessed physical activity using the International Physical 
Activity Questionnaire Short Form (IPAQ-S) (6) which was scored based on the 
Guidelines for Data Processing and Analysis of the International Physical Activity 
Questionnaire (7).  This tool has been validated in young adult research reflecting 
habitual physical activity levels of low, moderate and vigorous activity (6, 8).  
Participants were asked to report their frequency (days per week) and duration 
(time in minutes) of low, moderate, and vigorous physical activity over the past 
seven days.  Physical activity is expressed in metabolic equivalents (METs) in 
METs/minute/week (METs-min/wk); METs-min is the product of the MET score 
of an activity multiplied by the minutes performed (9).  Metabolic equivalents 
were calculated using the scoring protocol: 1 MET= resting energy expenditure, 
3.3 METs=walking, 4 METs=moderate intensity physical activity, and 8 
METs=vigorous intensity physical activity (10).  These values were each 
multiplied by the amount of minute each activity was performed and the amount of 
days (i.e. walking MET-min/week = 3.3 x walking minutes x walking days). 
 
Required Training 
 All study staff that worked with blood and hazardous waste completed the 
URI Blood Borne Pathogens and Hazardous Waste Management Training courses 
and were certified by the Collaborative Institutional Training Initiative Program 
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for Humans Subjects Protection.  All study staff were properly trained to perform 
anthropometric, clinical, biochemical and dietary assessment measurements. 
Table 2.  Study Timeline. 
 9/10 10/10 11/10 12/10 1/11 2/11 
Biochemical 
Assays 
 X X    
Data Entry X X X    
Data Analysis   X X X  
Manuscript      X 
 
Methodology for Primary Aim Hypothesis #1:  
Participants classified in the three different weight categories will have different 
eating rates. 
Dietary data was collected using 24 hour recalls (24HR), and analyzed by 
the Nutrition Data System for Research (NDSR) software versions 2007, 2008, 
and 2009 (Nutrition Coordinating Center, University of Minnesota, Minneapolis, 
MN).  The NDSR program is a validated dietary assessment tool developed to 
minimize the underreporting of dietary intake and to increase accuracy (11, 12).  
All study participants completed three 24HR recalls with trained study personnel: 
one in-person and two over the phone.  Recalls were collected on three non-
consecutive days (two weekdays and one weekend day);  as this method provides a 
good estimate of an individual’s usual intake (13, 14).  The 24HR was used to 
gather the participant’s food and dietary supplement intake within the past 24 
87 
 
hours, using a multiple-pass system.  The interviewer asked a series of guided 
computer-generated questions regarding food and beverage intake in the past 24 
hours.  This interactive program prompts the interviewer to probe for detailed 
information using neutral and non-leading questions about specific quantities, 
brand names and cooking methods for each food.  The participant is first asked for 
a quick list of foods consumed, then the interviewer probes for details of the foods 
consumed including types, amounts, additions/toppings, and preparation method.  
Then finally the final pass of the interview includes a review of the foods 
consumed, details of the food eaten, and amounts consumed; thus the interviewee 
can correct any data that is inaccurate (13).  In addition to the NDSR prompted 
questions, both studies asked two other questions: 1) How many individuals did 
you eat this meal with? and 2) How long did you spend eating this meal?  
Participants also received food amounts booklets designed by the Nutrition 
Coordinating Center at the University of Minnesota at the first 24HR, which they 
kept for the additional 24HR’s,  The food amounts booklet to help participants 
better estimate amount and sizes of foods eaten.  During this first, in-person 24HR, 
Nasco food models (eNASCO, Fort Atkinson, WI) were available to help 
participants visually estimate portion sizes and accurately estimate the amount of 
the food consumed.  
Based on previous research, eating rate was expressed as grams of food 
consumed per second and included all foods and only beverages that provide ≥5 
kilocalories per 100 grams (15).  The total number of grams of food and seconds 
of meal consumption time were determined and expressed as the mean per day.  
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The means of grams of food consumed and seconds of meal consumption time 
were then averaged for a total mean of the three 24HRs.  Those two means were 
used to calculate grams of food consumed per second, which is how eating rate 
was defined. 
 
Methodology for Primary Aim Hypothesis #2: 
Participants classified in the three different weight categories will have different 
total fasting ghrelin concentrations. 
All samples were labeled with the participant ID number and processed 
according to protocol stated in the above Biochemical section.  Plasma samples 
will be removed from the freezer and thawed to room temperature to complete the 
ghrelin assays.  Plasma unacylated ghrelin concentrations were measured in 
duplicate using an enzyme-linked immunosorbent assay (ELISA) kit 96 well plate 
assay (manufactured by SPI-Bio, Montigny le Bretonneux, France and distributed 
by ALPCO Diagnostics, Salem, NH).  Ghrelin will be processed according to the 
protocol provided below.   Different tips to pipette the buffer, standard, quality 
control, samples, tracer, and other reagents were used throughout the assay 
procedure.  Briefly, once all samples are at room temperature, and reagents are 
reconstituted, the wash buffer was prepared by diluting 1 mL into 400 mL of 
distilled or de-ionized water and 200 µl of the tween 20 reagent.  The well plate 
was removed from the packet and sufficient strips with be used, each well was 
rinsed with 300 µl of wash buffer five times.  Just before the reagents and samples 
were distributed, the buffer was removed from the wells by inverting the plate and 
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drying by inversion on absorbent paper.  The provided suggested plate layout was 
used. The contents of each well were recorded, using sample ID numbers, on the 
sheet provided by the kit.  The first column was left empty for blanking Ellman’s 
reagent. One hundred microliters of the EIA buffer was distributed to each Non-
Specific Binding well.  After, 100 µl of each of the eight standards was dispensed 
in duplicate to the appropriate wells. The lowest concentration standard was used 
first and the pipette tip was equilibrated in the next higher standard before 
pippetting. Then, 100 µl of the quality control and samples were dispensed in 
duplicates into the appropriate wells.  If there were any highly concentrated 
samples they were diluted in the EIA buffer.  Then 100 µl of the anti-unacylated 
ghrelin-AChE tracer was dispensed in each well except for the blank wells.  The 
well plate was then covered with adhesive film and incubated for three hours at 
room temperature.  After incubation, Ellman’s reagent was reconstituted.  The well 
plate was washed five times with the wash buffer, with 300 µl being dispensed into 
each well.  The well plate then was shaken on an orbital shaker for five minutes 
and then re-washed five times with 300 µl of the wash buffer dispensed into each 
well.  The liquid was removed by inverting the plate and drying by inversion on 
absorbent paper.  After, 200 µl of Ellman’s reagent was dispensed into all 96 
wells.  The well plate was then incubated in darkness and placed on an orbital 
shaker for optimal development.  The well plate was read at 405 nm and 414 nm 
after 30 to 60 minutes from adding Ellman’s reagent.  The ghrelin protocol was 
properly entered and set up on a Gen 5.1.08 Data Analysis software (BioTek 
Instruments Inc., Winooski, VT) in order to obtain and analyze ghrelin 
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concentrations.  All readings were used for analysis if the coefficient of variation 
(CV) values were ≤15%; samples were re-run if above 15%.  
 
Methodology for Secondary Aim Hypothesis:  
Participants classified in the three different weight status categories will have 
different energy densities  
Energy density was calculated using the average energy intake in 
kilocalories and food intake in grams of the three 24HRs.  The total number of 
kcals and grams were expressed as means per day.  The means of kcals of energy 
intake and grams of food intake were then averaged for a total mean of the three 
24HRs.  Those two means were used to calculate kcals of energy intake per gram 
of food, which is how energy density was defined.  There is no agreed upon 
method for calculating energy density as many different methodologies for 
calculation are proposed and recognized in nutrition research (16).  In this study, 
energy density was calculated using total energy intake of meal in kilocalories 
divided by total weight of the meal in grams, and is expressed as 
kilocalories/gram.  Energy density included all meals and snacks except for 
beverages containing at ≤5 kilocalories/100 grams (16).   Ledikwe et al (16) used 
this method in a free-living population and found a significant positive relationship 
between energy density and total reported energy intake.   
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DATA ANALYSIS AND STATISTICS 
 To maintain confidentiality, participants’ identification number contained 
no identifying information.  The list of names and ID numbers is kept locked in a 
filing cabinet located in Dr. Lofgren’s office, Ranger Hall Room 301 Ranger Hall 
on the Kingston campus at URI.  
  
Sample Size 
One-way analyses of variance (ANOVA) for ghrelin concentrations and 
eating rate were used to calculate sample size needed as they are the primary 
outcomes. The ANOVA for ghrelin only required six participants to achieve a 
power of 0.8. The ANOVA for eating rate required 78 participants to achieve a 
power of 0.8 with a large effect size f=0.4; an effect similar to that found by 
Laessle et al (2007) as interpreted by Cohen (17), with an expected difference of 
1.2 grams/second between normal weight and overweight/obese groups.  In order 
to have a total of 78 participants, 26 will be needed for each weight status 
classification: normal weight, overweight, and obese.  Participants with full data 
sets were randomly selected and 44 BFF and 34 Hatch participants were used.  
Significance was set at α=0.025 by applying the Bonferroni correction to account 
for power calculations for the two main analyses. 
Analysis 
 Data analyses were performed using the Statistical Package for the Social 
Sciences (SPSS) for Windows 19.0 (IBM Corp., Somers, NY).  Normality was 
assessed by examining skewness and kurtosis, and non-normally distributed data.   
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Outliers that were greater than three standard deviations from the mean were 
removed for TAG (n=1), IPAQ (n=2), percent kilocalories from fat (n=1) and 
energy density (n= 1).  Descriptive statistics were reported in mean and standard 
deviations for age, weight, height, BMI, WC, blood pressure, TC, HDL-C, LDL-C, 
TAG, GLC, total energy in kilocalories, % kilocalories from fat, protein, and 
carbohydrates, IPAQ, ghrelin and eating rate; frequencies and percentages were 
reported for weight status categories.  Significance was set at p<0.05. 
Primary Analysis 
Two ANOVA’s were run for the primary analyses, one examined the 
eating rate differences across the three weight statuses and the other examined the 
ghrelin differences across the same weight statuses. If any significant differences 
were found between groups, a Tukey follow-up test was used to find where those 
differences occurred.   
Secondary Analyses 
For secondary analyses, independent samples t-tests were used to compare 
the effect of eating rate on ghrelin concentrations and energy density. 
 
RESOURCES REQUIRED 
No university resources were required other than departmental computers, 
laboratory equipment and data analysis software.   Laboratory supplies such as 
pipettes, pipette tips, plastic microtubes, glass beakers and gloves were used to 
perform biochemical analysis.  Data and samples from the Nutritional Assessment 
and Chronic Disease Risk Factor Identification in Young Adults (IRB# HU0708-
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029) and the Best Foot Forward Study (IRB# HU0809-043) were used.  Dr. Ingrid 
Lofgren provided funding necessary to buy the ELISA kits and laboratory 
supplies. Dr. Katherine Peterson provided laboratory machines and equipment. 
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Appendix C: BFF Phase 1 Participant Survey 
 
BFF Online Survey Questions 
Welcome to the BFF Study! 
Please answer all of the following questions. 
Personal Information 
 
1. Please enter your URI student ID (All information will remain confidential) 
2. What is your e-mail? 
3. What is a phone number where we can reach you? 
 
Please answer all of the following questions....... 
 
1. What is your gender? 
Male or Female 
2. What is your current age? 
Under 18 
18 
19 
20 
21 
22 
23 
24 
Over 24 
 
3. What is your race or ethnic group? 
White (not of Hispanic origin) 
Black (not of Hispanic origin) 
Hispanic/Latino 
American Indian/Alaska Native 
Asian/Pacific Islander 
Other 
4. Where do you live? 
On-campus or Off-campus 
5. What is your major? 
Agricultural Sciences 
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Biological Sciences 
Business Administration 
Education 
English 
Exercise Science 
Fine Arts 
Humanities 
Kinesiology/Physical Education 
Nutrition and Food Sciences 
Social Science 
Undeclared 
Other 
Consent Form 
Can I participate? 
You must be 
• 18-24 years of age 
• A URI student 
• Willing to complete an on-line questionnaire. 
You must not Be: 
• Pregnant or lactating 
What will I be asked to do? 
If you choose to participate, you will be asked to: 
• Complete an online survey (approximately 20 minutes). 
What do I get out of it? 
You may be eligible to participate in a weight-loss study being done by the 
Nutrition and Food Science Department. 
Risks 
There is no risk in participating in this survey. 
Voluntary Participation 
Your participation is voluntary. You may stop participating in this survey at any 
point. 
Confidentiality 
All information that you provide will be kept confidential and your privacy will be 
protected to the maximum extent allowable by law. The website is password 
protected for both the researcher and subjects. The data will be stored on a disk in 
the Lipid Lab at the University of Rhode Island. Printouts of the data will be stored 
in locked offices at The University of Rhode Island for up to 5 years (as required 
by law) and then destroyed. Data will be reported in summary format, and no 
names will be used. 
Questions 
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If you have any questions or concerns, please contact the researchers listed below. 
If you have concerns regarding your rights as a research participant, please contact 
the human subjects representative listed below. 
Researchers: 
Emily Cook 
email: lipidlab@etal.uri.edu (Subject: BFF) 
or 
Ingrid Lofgren 
email: ingridlofgren@uri.edu 
 
Human Subjects Representative: 
Vice President for Research and Economic Development 70 Lower College Road 
University of Rhode Island 
Kingston, RI 02881 Phone 
(401) 874-4328. 
email: robind@uri.edu 
 
This project has been reviewed and approved by the human subject review board 
of the University of Rhode Island. 
Thank you for your time and interest in this study. 
Continuing in this study indicates that you have read and understand the above 
information. If you would like a copy of this form, please print it now. 
1. Continuing in this study indicates that you have read and understand the 
above information. 
I am ready to begin the survey. 
I am not interested in this study. 
Dietary History 
1. How many meals (i.e., breakfast, lunch, dinner) do you eat per day? 
2. How many snacks (i.e.; candy/energy bars, chips, pieces of fruit) do you eat 
per day? 
3. How many days per week do you eat breakfast? 
4. How fast is your rate of eating? 
very slow 
relatively slow 
medium 
relatively fast 
very fast 
5. Choose the statement that best describes your typical eating behavior. 
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I always eat whatever I want, whenever I want. 
I often eat whatever I want, whenever I want. 
I only sometimes eat whatever I want, whenever I want. 
I often refrain from eating what I want but often "give in" and eat it anyway. 
I often refrain from eating what I want and rarely "give in" and eat it anyway. 
I often refrain from eating what I want and never "give in" and eat it anyway. 
Body Weight History 
1. What is the length of time you have maintained your present weight? 
Years? Months? Days? 
2. How tall are you? 
3. How much do you weigh? 
4. How much would you like to weigh? 
5. How many times has your weight fluctuated by at least 6. Please describe 
any long-term weight changes you have experienced (e.g., lost 50 lb. in 1995): 
7. How would you describe the typical weight of your parents over the last 
few years? 
Your Mother: Underweight? Just right? Overweight? Obese? Unknown? 
Your Father: Underweight? Just right? Overweight? Obese? Unknown? 
8. What is the amount of moderate or vigorous activity (such as brisk 
walking, jogging, biking, aerobics, or yard work) you do in addition to your 
normal daily routine, most days? 
Less than 30 minutes 
30 - 60 minutes 
More than 60 minutes 
9. How many hours do you work (a paying job) per week?  
0-3 hours 
4-10 hours 
10-20 hours 
20-30 hours 
30-40 hours 
More than 40 hours 
10. Are you currently participating in a sports team or sports club? 
Yes or No 
Fruit Intake 
Please use the following information to answer the questions on this page: 
1 CUP OF FRUIT EQUALS  
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1 cup fruit  
1 small apple  
8 large strawberries  
2 large plums  
32 seedless grapes  
1 cup 100% juice  
1/2 cup cooked fruit 
1. About how many cups of FRUIT (including 100% pure fruit juice) do you 
eat or drink each day?  
None 
1/2 to 1 cup 
1 to 2 cups 
2 to 3 cups 
3 to 4 cups 
4 cups or more 
2. How many cups of FRUITS do you think you should eat each day for good 
health? 
None 
1/2 to 1 cup 
1 to 2 cups 
2 to 3 cups 
3 to 4 cups 
4 cups or more  
Vegetable Intake 
Please use the following information to answer the questions on this page: 
1 CUP OF VEGETABLES EQUALS 
1 cup of vegetables 
5 broccoli spears 5 inches long 
1 cup cooked leafy greens 
2 cups lettuce or raw greens 
12 baby carrots 
1 large potato or sweet potato 
2 large celery sticks 
1 cup cooked beans 
 
 
1. About how many cups of VEGETABLES (including 100% vegetable 
juice) do you eat or drink each day?  
None 
1/2 to 1 cup 
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1 to 2 cups 
2 to 3 cups 
3 to 4 cups 
4 cups or more  
2. About how many cups of VEGETABLES (including 100% vegetable juice) 
do you think you should eat each day for good health?  
None 
1/2 to 1 cup 
1 to 2 cups 
2 to 3 cups 
3 to 4 cups 
4 cups or more  
Eating Competence 
These questions are about your eating and food-providing skills, attitudes, and 
behaviors. As you answer the questions, think about how often you feel or behave 
a particular way with your eating. Please select your response. 
1. I am relaxed about eating.  
Always 
Often 
Sometimes 
Rarely 
Never 
2. I am comfortable about eating enough. 
Always 
Often 
Sometimes 
Rarely 
Never 
3. I enjoy food and eating. 
Always 
Often 
Sometimes 
Rarely 
Never 
4. I am comfortable with my enjoyment of food and eating. 
Always 
Often 
Sometimes 
Rarely 
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Never 
5. I experiment with new food and learn to like it. 
Always 
Often 
Sometimes 
Rarely 
Never 
6. I feel it is okay to eat food that I like.  
Always 
Often 
Sometimes 
Rarely 
Never 
7. If the situation demands, I can “make do” by eating food I don’t much care 
for.  
Always 
Often 
Sometimes 
Rarely 
Never 
8. I eat a wide variety of foods.  
Always 
Often 
Sometimes 
Rarely 
Never 
9. I assume I will get enough to eat.  
Always 
Often 
Sometimes 
Rarely 
Never 
10. I eat as much as I am hungry for. 
Always 
Often 
Sometimes 
Rarely 
Never 
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11. I eat until I feel satisfied. 
Always 
Often 
Sometimes 
Rarely 
Never 
12. I tune into food and pay attention to myself when I eat. 
Always 
Often 
Sometimes 
Rarely 
Never 
13. I make time to eat. 
Always 
Often 
Sometimes 
Rarely 
Never 
14. I have regular meals. 
Always 
Often 
Sometimes 
Rarely 
Never 
15. I think about nutrition when I choose what I eat. 
Always 
Often 
Sometimes 
Rarely 
Never 
16. I generally plan for feeding myself. I don’t just grab food when I get 
hungry. 
Always 
Often 
Sometimes 
Rarely 
Never 
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WEIGHT RELATED BEHAVIORS QUESTIONNAIRE: Physical Activity 
Behaviors 
Please choose the response that best expresses how well each statement describes 
you. 
1. I find being physically active gives me a lot of energy. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
2. I feel good physically after I’ve exercised. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
3. I schedule all events in my life around my exercise routine (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
4. I schedule exercise at specific times of the week in order to maintain a 
routine. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
5. I set goals for myself in order to keep physically active. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
6. I make commitments to exercise and stick to them. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
7. I’m just too lazy to exercise regularly. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
8. I make back up plans to be sure I get enough exercise. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
9. Being physically active gives me a strong sense of accomplishment. 
(Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
10. I have too many things to do during the day and can never find time to 
exercise. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
11. My lack of motivation stops me from being physically active. (Describes 
me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
12. When I am exercising, I often feel as though I would rather be doing 
something else. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
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13. Being physically active improves my mood. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
14. I consider being physically active an effective way of relieving stress. 
(Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
15. I don't exercise as regularly when I get depressed or upset about 
something. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
WEIGHT RELATED BEHAVIORS QUESTIONNAIRE: Eating Behaviors 
Please choose the response that best expresses how well each statement describes 
you. 
1. I purposefully hold back at meals in order not to gain weight. (Describes 
me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
2. I tend to eat more when I am anxious, worried, or tense. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
3. I count calories as a conscious means of controlling my weight. (Describes 
me)  
Not at all; Slightly; More or Less; Pretty Well; Completely 
4. When I feel lonely I console myself by eating. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
5. I tend to eat more food than usual when I have more available places that 
serve or sell food. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
6. I tend to eat when I am disappointed or feel let down. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
7. I often refuse foods or drinks offered because I am concerned about my 
weight. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
8. If I see others eating, I have a strong desire to eat too. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
9. Some foods taste so good I eat more even when I am no longer hungry. 
(Describes me) 
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Not at all; Slightly; More or Less; Pretty Well; Completely 
10. When I have eaten too much during the day, I will often eat less than 
usual the following day. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
11. I often eat so quickly I don’t notice I’m full until I’ve eaten too much. 
(Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
12. If I eat more than usual during a meal, I try to make up for it at another 
meal. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
13. When I’m offered delicious food, it’s hard to resist eating it even if I’ve 
just eaten. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
14. I eat more when I’m having relationship problems. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
15. When I’m under a lot of stress, I eat more than I usually do. (Describes 
me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
16. When I know I’ll be eating a big meal during the day, I try to make up for 
it by eating less before or after that meal. (Describes me) 
Not at all; Slightly; More or Less; Pretty Well; Completely 
Mindful Attention Awareness Scale (MAAS) 
Below is a collection of statements about your everyday experience. Using the 1-6 
scale below, please indicate how frequently or infrequently you currently have 
each experience. Please answer according to what really reflects your experience 
rather than what you think your experience should be. 
1. Please answer according to what really reflects your experience rather than 
what you think your experience should be. 
-almost always -very frequently -somewhat frequently 
-somewhat infrequently -very infrequently -almost never 
I could be experiencing some emotion and not be conscious of it until some time 
later.  
I break or spill things because of carelessness, not paying attention, or thinking of 
something else.  
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I find it difficult to stay focused on what’s happening in the present.  
I tend to walk quickly to get where I’m going without paying attention to what I 
experience along the way.  
I tend not to notice feelings of physical tension or discomfort until they really grab 
my attention.  
I forget a person’s name almost as soon as I’ve been told it for the first time.  
It seems I am “running on automatic” without much awareness of what I’m doing. 
I rush through activities without being really attentive to them.  
 
2. Please answer according to what really reflects your experience rather than 
what you think your experience should be. 
  -almost always -very frequently -somewhat frequently 
-somewhat infrequently -very infrequently -almost never 
I get so focused on the goal I want to achieve that I lose touch with what I am 
doing right now to get there.  
I do jobs or tasks automatically, without being aware of what I’m doing.  
I find myself listening to someone with one ear, doing something else at the same 
time.  
I drive places on “automatic pilot” and then wonder why I went there.  
I find myself preoccupied with the future or the past.  
I find myself doing things without paying attention.  
I snack without being aware that I’m eating.  
 
Physical Activity Readiness Questionnaire (PAR-Q) 
 
PAR-Q is designed to help you help yourself.  Many health benefits are associated 
with regular exercise, and the completion of PAR-Q is a sensible first step to take 
if you are planning to increase the amount of physical activity in your life. 
 
For most people, physical activity should not pose any problems or hazard. PAR-Q 
has been designed to identify the small number of adults for whom physical 
activity might be inappropriate or those who should have medical advise 
concerning the type of activity most suitable for them. 
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Common sense is your best guide in answering these few questions.  Please read 
the carefully and check YES or NO opposite the question if it applies to you.  If 
yes, please explain. 
 
YES      NO 
 
____     ____ 1.  Has your doctor ever said you have heart trouble? 
  Yes,  ____________________________________________  
____     ____ 2. Do you frequently have pains in your heart and chest? 
  Yes,  ____________________________________________  
____     ____ 3. Do you often feel fain or have spells of severe dizziness? 
  Yes,  ____________________________________________  
____     ____ 4. Has a doctor ever said your blood pressure was too high? 
  Yes,  ____________________________________________  
____     ____ 5. Has your doctor ever told you that you have a bone or joint 
problem(s), such as arthritis that has been aggravated by exercise,  or might be 
made  
worse with exercise? 
  Yes,  ____________________________________________  
____     ____ 6. Is there a good physical reason, not mentioned here, why 
you should notfollow an activity program even if you wanted to? 
  Yes,  ____________________________________________  
____     ____ 7. Are you over age 60 and not accustomed to vigorous 
exercise? 
  Yes,  ____________________________________________  
____     ____ 8. Do you suffer from any problems of the lower back, i.e., 
chronic pain, or numbness? 
  Yes,  ____________________________________________  
____     ____ 9. Are you currently taking any medications?  If YES, please 
specify. 
  Yes,  ____________________________________________  
____     ____ 10. Do you currently have a disability or a communicable 
disease?  If YES,  
  Please specify, 
  Yes,  ____________________________________________  
 
If you answered NO to all questions above, it gives a general indication that you 
may participate in physical and aerobic fitness activities and/or fitness evaluation 
testing.  The fact that you answered NO to the above questions, is no guarantee 
that you will have a normal response to exercise.  If you answered Yes to any of 
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the above questions, then you may need written permission from a physician 
before participating in physical and aerobic fitness activities and/or fitness 
evaluation testing. 
 
International Physical Activity Questionnaire 
INSTRUCTIONS: We are interested in finding out about the kinds of physical 
activities that people do as part of their everyday lives. The questions will ask you 
about the time you spent being physically active in the last 7 days. Please answer 
each question even if you do not consider yourself to be an active person. Please 
think about the activities you do at work, as part of your house and yard work, to 
get from place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days. Vigorous 
physical activities refer to activities that take hard physical effort and make you 
breathe much harder than normal. Think only about those physical activities that 
you did for at least 10 minutes at a time. 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling? 
0 days per week 
1 day per week 
2 days per week 
3 days per week 
4 days per week 
5 days per week 
6 days per week 
7 days per week 
2. How much time did you usually spend doing vigorous physical activities on 
one of those days? 
Think about all the moderate activities that you did in the last 7 days. Moderate 
activities refer to activities that take moderate physical effort and make you 
breathe somewhat harder than normal. Think only about those physical activities 
that you did for at least 10 minutes at a time. 
1. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles 
tennis? Do not include walking. 
0 days per week 
1 day per week 
2 days per week 
3 days per week 
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4 days per week 
5 days per week 
6 days per week 
7 days per week 
2. How much time did you usually spend doing moderate physical activities 
on one of those days? 
Think about the time you spent walking in the last 7 days. This includes at work 
and at home, walking to travel from place to place, and any other walking that you 
might do solely for recreation, sport, exercise, or leisure. 
1. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time? 
0 days per week 
1 day per week 
2 days per week 
3 days per week 
4 days per week 
5 days per week 
6 days per week 
7 days per week 
2. How much time did you usually spend walking on one of those days? 
This question is about the time you spent sitting on weekdays during the last 7 
days. Include time spent at work, at home, while doing course work and during 
leisure time. This may include time spent sitting at a desk, visiting friends, reading, 
or sitting or lying down to watch television. 
1. During the last 7 days, how much time did you spend sitting on a week day? 
2. During the last 7 days, on how many days did you do any strength training 
activities designed to strengthen muscles such as lifting weights, push-ups, or 
sit-ups? 
1 day 
2 days 
3 days 
4 days 
5 days 
6 days 
7 days 
No strengthening exercises 
3. How much time did you usually spend doing strength training activities on 
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one of those days? 
Physical Activity Behaviors 
Directions: For each of the statements below, please choose the response which 
describes you best. 
-Not at all   -Slightly  -More or Less -Pretty Well   -Completely 
I find being physically active gives me a lot of energy.  
I feel good physically after I’ve exercised.  
I schedule all events in my life around my exercise routine.  
I schedule exercise at specific times of the week in order to maintain a routine.  
I set goals for myself in order to keep physically active.  
I’m often so tired that I don’t have enough energy to exercise.  
I’m just too lazy to exercise regularly.  
I make back up plans to be sure I get enough exercise.  
Being physically active gives me a strong sense of accomplishment.  
My lack of motivation stops me from being physically active.  
When I am exercising I often feel as though I would rather be doing something 
else.  
I consider being physically active an effective way of relieving stress.  
Being physically active improves my state of mind.  
I don’t exercise as regularly when I get depressed or upset about something.  
I try to exercise at the same time on the same days each week to help stay 
physically active.  
University of Rhode Island Pittsburgh Sleep Quality Index 
Instructions: The following questions relate to your usual sleep habits during the 
past month only. Your answers should indicate the most accurate reply for the 
majority of days and nights in the past month. Please answer all questions. 
1. During the past month,when have you usually gone to bed? 
2. How long (in minutes) has it taken you to fall asleep each night? 
3. When have you usually gotten up in the morning? 
4. How many hours of actual sleep do you usually get (This may be different 
than the number of hours you spend in bed)? 
University of Rhode Island Pittsburgh Sleep Quality Index (continued) 
1. During the past month, how often have you had trouble sleeping because you… 
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-not during the past month -less than once a week  -once or twice a 
week -three or more times a week 
Cannot get to sleep within 30 minutes  
Wake up in the middle of the night or early morning 
Have to get up to use the bathroom  
Cannot breathe comfortably  
Cough or snore loudly 
Feel too cold  
Feel too hot  
Have bad dreams  
Have pain  
During the past month, how often have you taken medicine (prescribed or over-
the-counter) to help you sleep?  
During the past month, how often have you had trouble staying awake while in 
class, studying, eating meals, or engaging in social activity? 
During the past month, how much of a problem has it been for you to keep up 
enthusiasm to get things done?  
Other reason(s), please describe, including how often you have had trouble 
sleeping because of this reason(s):  
Please describe: 
2. During the past month, how would you rate your sleep quality overall? 
Very good 
Fairly good 
Fairly bad 
Very bad 
Motivational Change 
1. Rate the degree to which the following MOTIVATED you to make a change to 
improve your health 
-Not at all motivating  -Slightly motivating  -Moderately motivating  -Highly 
motivating -Most motivating 
Completing the on-line surveys  
Feedback on my BMI  
Feedback on my waist circumference 
Feedback on my blood pressure  
Attending the classes  
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Completing the homework for class  
Ineligible 
Based on your previous response, you are ineligible to participate in this study. 
Thank you for your interest. 
If you have any questions regarding your ineligibility please email Emily Cook or 
Chelsea Smith at lipidlab@etal.uri.edu. You may close out this screen at this time. 
Thank You! 
Thank you for participating in the BFF Survey! We will be in contact with you 
soon and schedule your next appointment. 
You may close out this screen at this time. 
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Appendix E: BFF Consent Form for Research 
The University of Rhode Island 
Department of Nutrition & Food Sciences 
106 Ranger Hall, Kingston, RI 02881 
 
CONSENT FORM FOR RESEARCH 
 
Title of Project:  The University of Rhode Island Best Foot Forward (BFF) Study. 
 
You have been asked and have elected to take part in the research project 
described below.  The researchers will explain the project to you in detail. Please 
feel free to ask questions.  If you have more questions later, Dr. Ingrid Lofgren 
(401-874-5706), or Emily Cook (401-874-2785) from the Department of Nutrition 
and Food Sciences at the University of Rhode Island (URI), will discuss them with 
you.  
 
Description of the project: 
The primary purpose of this study is to assess the impact of two combined dietary 
and exercise interventions on chronic disease health risks in young, female adults.  
This study will compare various outcomes after eight weeks of intentional weight 
loss in the two groups. One group, the Manual Intervention Group, will receive 
diet and physical activity education via manual instruction only at baseline and 
will receive no additional contact with study staff until post-intervention. The 
other group, the Step Forward Intervention Group, will receive diet and physical 
activity education via group and one-on-one meetings. Participants in both groups 
will be assessed for changes in weight, body composition, blood pressure, blood 
sugar and lipids, nutrient metabolism, urine properties, and how certain genes may 
influence the changes. To participate in this study, you must be female, between 
18 and 24 years old, and you may not be pregnant or lactating. You are not eligible 
for this study if you have a BMI of less than 25 kg/m2. You are not eligible for this 
study if you have diabetes (Type I or Type II), cancer, coronary heart disease, liver 
disease, a bleeding disorder, or if you are on lipid lowering medications. All 
phases of this study will be completed on the URI campus. You will receive $150 
once you complete all parts of this study.  
 
What will be done: 
If you choose to participate, the study requires your involvement in 4 phases.  
During phase 1, you will complete 4 preliminary assessment visits over 2 weeks. 
Phase 2 will last 8 weeks and all participants will receive dietary education and 
pedometers to use. During phase 2 some participants will be involved in additional 
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activities that include weekly meetings. For phase 3 you will complete 4 post-
assessment visits similar to the phase 1 assessment visits. Phases 1 through 3 will 
be completed before the end of this semester. During phase 4 you will be contacted 
6 months after the completion of phase 3. Phase 4 includes a total of 4 visits with 
similar activities to the assessment visits in phase 1.  
 
Phase 1: Assessment: 
 
Assessment Visit 1 (20-30 minutes):  
• You will be asked questions about what you ate the day before. You do not 
need to write anything down prior to coming. 
 
Day Prior to Assessment Visit 2: 
• For the 12 hours prior to the second assessment visit, you will be asked not 
to eat or drink anything unless it’s water. We encourage you to drink as 
much water as you would like. For example, if your screening visit is 
scheduled for 8 am on Tuesday do not eat or drink anything except water 
after 8 pm on Monday evening. 
 
 
Assessment Visit 2 (20-30 minutes): 
• Your height, weight, and waist circumference will be measured. 
 
 
Assessment Visit 2 (20-30 minutes - continued): 
• A 7-ml blood draw (less than 1 tablespoon) will be taken. The blood draw 
will be used to analyze blood sugar and lipids, molecules that impact 
metabolism-like hormones, blood proteins, and your DNA (genetic 
material).   
• A urine sample will be collected in a glass or plastic urine specimen cup 
labeled with a non-identifying ID number. You will be sent to private, 
gender specific bathroom to collect the sample. 
 
Day Prior to Assessment Visit 3: 
• Again, for the 12 hours prior to the second assessment visit, you will be 
asked not to eat or drink anything unless it’s water.  
 
Assessment Visit 3 (20-30 minutes): 
• Blood pressure will be measured.  
• A 42-ml blood draw (approximately 4 tablespoons) will be taken.  
• A urine sample will be collected in a private gender specific bathroom. 
 
Assessment Visit 4 (90 minutes): 
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• Your percent body fat will be performed using an air-displacement 
machine (“BodPod”) located in the Independence Square II building.  This 
will require you to sit still in a chamber a wearing a bathing suit for about 
10 minutes at a time totaling less than 30 total minutes for the entire 
procedure. 
• VO2max will be measured on a treadmill using a reviewed protocol. The test 
will begin at a 2.5% grade and will remain at a constant speed of 3 mph 
throughout the length of the test. The percent grade will slowly increase 
throughout the duration of the test at a 2.5% increase every 2 minutes. The 
test will continue until you signal that you are exhausted. You will wear a 
mouthpiece (like that worn by a scuba diver, connected to a small tube) 
during the entire test. You will be provided with your own mouthpiece for 
the duration of the study. 
• A urine sample will be collected in a private, gender specific bathroom. 
 
Phone Calls: 
• You will receive two phone calls from research staff prior to the start of 
phase 2. You will be asked questions about what you ate the day before. 
You do not need to write anything down prior to these phone calls. 
 
Phase 2: Intervention: 
• At the end of the phase 1 (assessment), you will be randomly assigned to 
either the Manual Intervention Group or the Step Forward Intervention 
Group for the second phase. You are not allowed to choose which group 
you will be assigned to. Participants in each group, the Manual Intervention 
Group and the Step Forward Intervention Group, will be given dietary and 
physical activity information and instructed on how to use a study-provided 
pedometer. The goal of both intervention groups is weight loss. The 
participants in the Step Forward Intervention Group will also participate in 
regularly scheduled group and one-on-one meetings with research staff at 
to review nutrition and physical activity information.  
 
 
Phase 3: Post Assessment Visits: 
• The four post assessment procedures and two phone calls are similar to the 
phase 1 assessment visits. 
 
Phase 4: Six month follow-up: 
• In fall 2009 you will be contacted via telephone and/or e-mail to complete 
the follow-up assessment visits. The four post assessment visits and two 
phone calls are very similar to the phase 1 and 3 assessment visits. 
 
******************************************************************
******************* 
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Benefits of this study: 
Participating in this study may result in weight-loss and may reduce your risk for 
heart disease. Participation will result in increased knowledge of weight-loss 
techniques, healthy eating, and physical activity information. You may keep the 
study-provided pedometers once the study is over. You will gain knowledge about 
your health status (examples: blood pressure, total cholesterol, low density 
lipoprotein cholesterol, high density lipoprotein cholesterol, and triglycerides), 
your body composition (examples: BMI, % lean body mass), and your 
cardiovascular fitness. These values are not diagnostic, however, if you are 
concerned, you can share the results with your health practitioner and tests can be 
repeated if deemed necessary. The genetic information we obtain from your blood 
sample will help the researchers in this study better understand the role genetics 
plays in chronic disease risks for young adults. The information we obtain from 
your urine sample will be analyzed for the presence of various compounds that 
provide information about nutrient metabolism such as bis-phenol A. There will be 
no direct benefit to you from genetic or urine analysis as you will not be provided 
with these results or information regarding your DNA or urine tests. 
 
Risks or discomfort: 
There are no known risks for the following procedures: completing the 
questionnaires, having height, weight, and waist circumference measured, body 
composition via the BodPod and urine collection. Even though experienced 
personnel will perform the blood draw using a sterile technique, there are a few 
risks associated with the procedure: there is a small chance of discomfort from the 
needle, bruising, formation of blood clot, and infection. A trained professional will 
perform the blood draw and we will take all steps possible to minimize the risks to 
you.  
 
It is possible that you could slip or fall while running on the treadmill for the 
VO2max test. For your safety you will be reminded to focus your attention on the 
treadmill belt and to stay in the center of the treadmill. Also there is a support 
railing at the front of the treadmill, and a technician will be stationed at the 
treadmill during all tests. Tiredness may occur after finishing the VO2max test. 
   
Confidentiality: 
All information collected in this study is confidential, and your name will not be 
identified and linked to any study data at any time to anyone other than the 
principle investigators of the study. All study data, including this consent form, 
will be locked and secured in our study lab (Ranger Hall, room 301). All 
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computer-based data will be kept on a computer that is password protected and all 
study paperwork will be stored in a locked file cabinet (locked file cabinet and 
password protected computer are in Ranger 301). An individual code will be 
assigned to you and will not be directly associated with your name. The 
researchers and URI will protect your privacy, unless they are required by law to 
report information to city, state or federal authorities, or give information to a 
court of law.  
 
 
Genetic testing: 
Previous research indicates that certain gene variations might influence body 
composition and lipid metabolism and exercise responses to exercise training and 
weight-loss. Only gene variations that are related to body composition, nutrient 
metabolism, and exercise responses will be examined using your DNA sample. 
Your DNA sample will be coded only with a study number without any personal 
identifiers (including initials or birth dates). A sample of your DNA will be 
collected during blood draw one. Your DNA sample will be stored for up to 30 
years in order to allow for pooling of data and more thorough analyses with future 
study data. For the 30 year storage period, URI will maintain a record of your 
personal identification (signed informed consent documentation) that is linkable to 
your DNA sample by your subject ID. This information will be locked in a file 
cabinet for sample location purposes if necessary. The information obtained from 
your DNA will be held at URI, at the lipid lab, for 30 years and will be shared only 
with researchers from the URI in the form of a computerized database free of 
personal identifiers. Should the principle investigator (PI) relocate to a different 
institution after the completion of the study, your sample may also be moved to 
that institution with the PI. However, you still retain the right to have your sample 
destroyed by contacting the PI or URI’s Vice President for Graduate Studies, 
Research and Outreach. NO ADDITIONAL GENETIC TESTING beyond what 
you are consenting to by signing this document will be performed without your 
written permission. If you agree, you may be contacted during the 30 year storage 
period by these or other researchers associated with this project for permission to 
use your sample in research beyond the scope of this study. After the 30 year time 
period, all remaining samples will be destroyed. If you wish to have your DNA 
destroyed for these future analyses, you may do so by contacting Dr. Ingrid 
Lofgren (401-874-5706). 
 
Urine Samples: 
The urine samples will be sent to Angela Slitt, Professor of Biomedical and 
Pharmaceutical Sciences, here at URI for analysis. Urine samples will be analyzed 
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for the presence of various compounds that provide information about nutrient 
metabolism such as bis-phenol A. Bis-phenol A is a metabolite found in plastic 
food and drink containers. 
 
In case there is any injury to the subject:  
If you have any injury or discomfort as a result of the study, you should notify Dr. 
Ingrid Lofgren at (401) 874-5706, or Emily Cook (401-874-2785). Additionally, if 
this study causes you any injury, you should write or call the office of the Vice 
Provost for Graduate Studies, Research and Outreach, 70 Lower College Road, 
University of Rhode Island, Kingston, Rhode Island, telephone: (401) 874-4328.  
 
Decision to quit at any time: 
It is your decision and your decision alone whether or not you consent to 
participate in this study. You are free to ask questions about this study before you 
decide whether or not to consent to participate in it.  If you consent to participate 
in the study you are free to withdraw from participation at any time without 
penalty or coercion, or without any requirement that you provide an explanation to 
anyone of your decision to withdraw.  
 
Incentives:  
You will receive partial compensation ($100.00) after completing phase 1, 2, and 3 
of the study. You will receive an additional compensation ($50.00) after 
completion of phase 4.  
******************************************************************
******************* 
You have read and understand the above information in the consent form and have 
been given adequate opportunity to ask the investigators any questions you have 
about the study. Your questions, if any, have been answered by the investigators to 
your satisfaction. Your signature on this form means that you understand the 
information and you agree to voluntarily participate in this study. 
_________________________  ________________________ 
Signature of Participant   Signature of Researcher 
 
_________________________  ________________________ 
Typed/printed Name   Typed/printed name 
 
__________________________  _______________________ 
Date                 Date 
By signing again below you understand that a portion of your blood and/or DNA 
sample may also be used for potential future studies by the principle investigators 
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only. Your sample will be used only to examine body composition, nutrient 
metabolism, and bodily responses to exercise training and weight loss.   
 
________________________   ________________________ 
Signature of Participant    Date    
  
 
________________________   ________________________ 
Printed name of Participant               Date     
 
 
____________________________  ________________________ 
Signature of Researcher    Date 
 
 
By signing a third time below you are stating that you are willing to be contacted 
for involvement in future studies done at URI. 
 
________________________   ________________________ 
Signature of Participant            Contact phone number and E-
mail 
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Appendix F: BFF Assessment Materials 
NAME: _______________________  BIRTHDATE: __________________________ 
 
HOW DID YOU HEAR ABOUT THIS STUDY? 
_____________________________________________________________________ 
 
MAJOR: _______________________STUDENT ID: _______________________ 
 
HOME ADDRESS (OR CONACT INFORMATION INCASE YOU MOVE): 
________________________________________________________________________
__________________________________________________________________ 
 
DAY PHONE #: ____________________  CELL PHONE #: ___________________ 
 
E-MAIL ADDRESS: __________________________   
 
BEST WAY TO CONTACT YOU (Check any applicable choice):  
   
____ e-mail ____ day phone ____ cell phone ____ other, specify: 
 
 
NOTE: THE FOLLOWING IS FOR COMPENSATION PURPOSES ONLY. 
 
PAYMENT # 2 DATE _______ PPT ID #: _____________________ 
 
____ 6 MONTH FOLLOW UP ASSESSMENT 
 ____ 3 DIETARY RECALLS 
 ____ ASSESSMENT SHEET COMPLETE  
 
I __________________________ HAVE RECEIVED $50.00 FOR PARTICIPATION IN 
THE  
 (PARTICIPANT NAME) 
  BFF STUDY. 
 
PPT SIGNATURE: __________________________     DATE:__________________ 
 
 
PAYMENT #1  DATE _______ PPT ID #: __________________________ 
 
____ BASELINE ASSESSMENT   ____ POST INTERVENTION 
ASSESSMENT 
 ____ 3 DIETARY RECALLS  ____ 3 DIETARY RECALLS 
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 ____ ASSESSMENT SHEET COMPLETE ____ ASSESSMENT SHEET 
COMPLETE 
 
____ 8 WEEKS 
 
I __________________________ HAVE RECEIVED $100.00 FOR PARTICIPATION 
IN THE  
 (PARTICIPANT NAME) 
  BFF STUDY. 
 
PPT SIGNATURE: ________________________    DATE: ___________________ 
 
 
Assessment Checklist 
 
Date:  ___________Time:  _______ a.m. Visit:   Assessment#1  In-person recall 
visit 1 or 2____ 
Participant:  _____________________________ Subject ID No.  
_________________________ 
 
Assessment evaluator:   _______________________  
Questions to ask participant 
 
1. At what time did you last have something to eat? _________   a.m. or p.m. 
 
2. At what time did you last have something to drink? _________   a.m. or 
p.m. 
 
3. Have you had any caffeine, tobacco, or tobacco products today?    Yes      
 No 
If yes, please have participant explain:   
What: _______________________________________ 
When:  _________   a.m. or p.m. 
   
4. Are you currently ill?     Yes       No 
      If yes have participant 
explain:___________________________________________________
__ 
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5. Have you ever fainted or passed out while having blood drawn?   Yes      
 No 
 If yes, have participant 
explain:___________________________________________________
_ 
    
6. Is there any reason you feel you are unable to participate in testing today?    
 Yes       No 
If yes, have participant explain: 
____________________________________________________ 
 
7. Please ask participant if there is any additional information they would like 
to provide to the assessment staff member: 
____________________________________________________________
____________________________________________________________
________________________________ 
 
Reasons to Reschedule 
1. Reschedule if participant has eaten in the last 12 hours. 
2. Reschedule if participant drank something in the last 12 hours (exception 
water). 
3. Reschedule if participant had any caffeine, tobacco, or tobacco products in 
the last 4 hours 
4. Reschedule if participant has participated in structured exercise the day of 
or day before assessment. 
5. Reschedule if the participant is ill.  
6. Reschedule if participant states they are unable to participate today. 
 
Results 
 Participant is cleared for their assessment today. 
 Participant will need to be rescheduled because 
_____________________________________________  
 
Notes: 
Name:________________________    Date:_____________  
Date of Birth  _________ Gender    M  F  Height  ___ Weight  _____ 
Are you Hispanic or Latino?  ______________ 
Which one or more of the following would you say is your race? 
____White     ____Black or African American 
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____Asian     ____Native Hawaiian or other Pacific 
Islander 
____American Indian or Alaska Native ____Other (please specify 
_________) 
HEALTH HISTORY 
Have you been told that you have any of the following?  Check all that apply. 
_____Diabetes  _____Heart disease  _____Heart attack
 _____Cancer 
_____GI disorders _____Kidney disease  _____Liver disease
 _____Ulcers 
_____Thyroid disease _____High blood pressure _____High/borderline blood 
sugar 
_____Lung disease _____Stroke   _____Anemia 
Other:  _________________________________________________________________ 
 
Have you been told that anyone in your family have any of the following?  Check all that 
apply.   
M for mother, F for father, GM for grandmother, GF for grandfather, A for aunt, U for 
uncle, S for sibling, C for cousin. 
_____Diabetes  _____Heart disease  _____Heart attack
 _____Cancer 
_____GI disorders _____Kidney disease  _____Liver disease
 _____Ulcers 
____Thyroid disease _____High blood pressure _____High/borderline blood 
sugar 
_____Lung disease _____Stroke   _____Anemia 
Other:  
____________________________________________________________________ 
Do you have allergies? _____  Yes*     _____  No 
*If yes, please list any medication, environmental, or food allergies you have:  
___________________________________________________________ 
Have you ever had any surgeries?  _____  Yes*  _____  No 
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*If so, what surgeries have you had?  
__________________________________________________________ 
MEDICATION/SUPPLEMENT HISTORY 
What over-the-counter medication do you take at least one time a month? 
Name of medication Reason for taking Dose  Frequency  Duration of 
intake 
_________________ ______________ ____   _______
 _______________ 
_________________ ______________ ____   _______
 _______________ 
_________________ ______________ ____   _______
 _______________ 
________________ ______________ ____   _______
 _______________ 
MEDICATION/SUPPLEMENT HISTORY 
What over-the-counter vitamin or mineral supplements do you take at least one time a 
month? 
Name of supplement   Reason for taking Dose  Frequency Duration of 
intake 
_________________     _____________ ____   ______
 _______________ 
_________________    _____________ ____   ______
 _______________ 
_________________    _____________ ____   ______
 _______________ 
_________________    _____________ ____      ______ _______________ 
 
What prescription medications do you take at least one time a month?  Please include 
birth control. 
Name of medication    Reason for taking   Dose      Frequency   Duration of 
intake 
149 
 
________________    ______________   _____       ______   
_______________ 
________________    ______________   _____       ______   
_______________ 
________________    ______________   _____       ______   
_______________ 
________________    ______________   _____       ______   
_______________ 
 
To your knowledge, have you had your cholesterol levels checked?  
_____  Yes  _____  No  ______  Don’t know 
If yes, do you remember the results? (please list the results that you remember.) 
__________________________________________________________________
__________________________________________________________________
____ 
 
 
GENERAL HISTORY 
Would you say that in general, your health is  
_____  Excellent _____  Very good _____  Good _____  Fair _____  
Poor 
 
Do you use/did you use tobacco products?  _____  Yes  _____  
No   
  Current smoker: packs/day  ____________  Number of years  
_____ 
  Previous smoker: quit date  _____________ 
  Never  _____________ 
    
Do you use other tobacco products? _____  Yes, please specify below _____  
No 
_____  Pipe  _____  Cigar  _____  Snuff  _____  
Chew 
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Do you drink?  ___  No  ___  Yes Number of drinks/week  ___________ 
 
My current diet is   _____  Satisfactory  _____  
Unsatisfactory 
My current exercise/activity level is _____  Satisfactory  _____  
Unsatisfactory 
My current weight is    _____  Satisfactory  _____  
Unsatisfactory  
 
Caffeine Intake  _____  None  _____  Coffee/tea/soda _____  Cups/day 
 
Do you have any kind of health care coverage, including health insurance, prepaid plans 
such as HMOs, or government plans such as Medicare? 
  _____  Yes  _____  No _____  I don’t know 
About how long has it been since you last visited a doctor for a routine check-up?  A 
routine checkup is a general physical exam, not an exam for a specific injury, illness, or 
condition. 
_____  Within past year (anytime less than 12 months ago)   
_____  5 or more years ago 
_____  Within past 2 years (1 year but less than 2 years ago) 
_____  Don’t know/not sure 
_____  Within past 5 years (2 years but less than 5 years ago) 
_____  Never   
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About Genetic Research 
 
What is genetics? 
 
Genetics is the study of inheritance.  Genes are the instruction manuals for making 
building blocks called proteins which, combine in many ways to create all the 
parts of our bodies.  Genes also create unique body features called “traits”.  Some 
traits are visible, like eye color. Other traits are not like your body’s ability to fight 
certain diseases.  
 
What is genetic testing? 
 
Genetic testing identifies changes in chromosomes or genes.  Most of the time, 
testing is used to find changes that are associated with inherited disorders.  The 
results of a genetic test can confirm or rule out a suspected genetic condition or 
help determine a person's chance of developing or passing on a genetic disorder.   
 
Another type of testing called “genome scanning” looks at DNA variations on a 
more minute level known as single nucleotide polymorphism (SNP, pronounced 
“snip”).  Most SNPs are insignificant. However, some have effects on disease risk 
and vulnerability to disease-causing agents.  In many cases, SNPs are not related to 
specific risks but to a general increase in risk which may be important in research. 
 
Is having your DNA tested safe? 
 
The physical risks associated with most genetic tests are very small, particularly 
for those tests that require only a blood sample or cheek swab. 
 
Many people are also concerned about issues of privacy.  In the United States, 
federal law requires that this kind of medical information be kept confidential. 
 
Researchers take great care with DNA samples obtained from research volunteers.  
Researchers must obtain your permission to collect, analyze, and store your 
samples.  Researchers must also get your permission to use your DNA sample in 
future studies. 
 
Your stored DNA sample is not identifiable by donor.  Confidentiality is of utmost 
importance.  You have the right to request that your sample be discarded at 
anytime through the institution which collected the sample.  
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Genetic testing can only tell you if you have inherited the risk of developing a 
certain disease or condition.  Having a genetic risk does not mean you will develop 
a particular condition, but rather that you have a higher change of developing it 
than if you did not have the risk.  But genes are not the only thing.  What you eat, 
whether and how much you exercise and where you live and work are all factors 
that can profoundly affect your overall health.  
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Energy Metabolism Lab Appetite Rating Scale 
Subject # Subject Initials Visit # Condition ID Visit Date 
     
 
Clock Time: ________ (0) 
 
1.  How hungry are you right now? 
 
Not at all     
 Extremely 
 
2. How satisfied (satiated) are you right now? 
Not at all     
 Extremely 
 
3. How much could you eat right now? 
Nothing        Vast 
Quantities 
 
4. How thirsty are you right now? 
Not at all     Extremely 
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Energy Metabolism Lab Palatability Scale – Meal 
Subject # Subject Initials Visit # Condition ID Visit Date 
     
 
Clock Time: ________ (1 min) 
1. How pleasant do you find this meal to be? 
Not at all      Extremely 
 
2. How salty do you find this meal to be? 
Not at all      Extremely 
 
3. How much do you like the texture and consistency of this meal? 
Not at all      Extremely 
 
4.  How bitter do you find this meal to be? 
Not at all      Extremely 
 
5.  How tasty do you find this meal to be? 
Not at all      Extremely
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Energy Metabolism Lab Palatability Scale – Drink 
Subject # Subject Initials Visit # Condition ID Visit Date 
     
 
Clock Time: ________ (1 min) 
1.  How pleasant do you find this drink to be? 
Not at all      Extremely 
 
2.  How sweet do you find this drink to be? 
Not at all      Extremely 
 
3.  How sour do you find this drink to be? 
Not at all      Extremely 
 
4.  How bitter do you find this drink to be? 
Not at all      Extremely 
 
5.  How tasty do you find this drink to be? 
Not at all      Extremely 
  
 
 
Body Composition Measurements
BodPod 
Participant Involvement:
•    You will be asked to wear a bathing suit or anything tight and fitting such as
spandex and a sports bra.
• All jewelry and watches must be removed before the test can be performed so you 
can leave them at home or take them off there.
• The test is done in a comfortable, private room. 
• The test takes 5-10 minutes total.
 
 
Maximal Oxygen Uptake Measurements 
VO2max 
Participant Involvement:
• You will be asked to wear comfortable clothes to work out in, preferably shorts, a 
t-shirt and sneakers.
• You will be asked to walk on a treadmill at a constant speed and progressively 
increasing grade until you feel you are maximally fatigued and can’t proceed any 
further. 
• This test will not require you to run at anytime. 
• Each test takes about 30 minutes total, including set
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-up and equipment orientation.
 
 
 
 
  
 
 
BodPod Data Sheet –
 
 
 
 
Reading 1:  
Reading 2:  
Reading 3:  
Mean:          
 
 
Percent Body Fat: 
Body Weight:         
Fat Weight:             
Lean Weight:          
Lung Volume (predicted):
 
Comments: 
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Yamax Digi-Walker SW-701 
 
• Step counter – Accurately counts your steps while walking, jogging, or hiking 
• Displays number of steps taken, distance walked and calories burned 
• Cover helps protect from unexpected resets and keeps counts confidentially 
• Model is about 2” X 1 ½” X ¾” and weighs less than ¼ ounce 
• Your personal stride will be set on the pedometer along with your weight – 20 
feet / # of steps walked in 20 feet = stride 
• Please wear it on your hip and have it clipped onto your pants. Please do not 
wear it anywhere else such as your shoes 
• We will provide a log so you can write down how many steps you take each day 
• You will need to reset the step count on your pedometer every day before 
putting it on to get an accurate number for that day (Be sure to write down the 
number of steps you took before you press yellow ‘Reset’ button) 
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Blood Pressure Record Sheet – VO2max Test 
 
Resting BP 1    Resting BP 2    
 
 
Stage Time (min) BP (mmHg) 
1 2:00  
3 6:00  
5 10:00  
7 14:00  
8 16:00  
9 18:00  
10 20:00  
Recovery 2:00  
 
Post-Exercise BP    
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Name: 
 
Student ID#: 
 
Age: 
 
Ht. (in): 
 
Wt. (kg): 
 
Resting HR (bpm): 
 
Max HR: 220-age= 
  Speed 182 Grade (%) HR (bpm) RPE 
 Warm-Up     
 1:00 3.0 0   
Stage Exercise     
1 0:00 3.0 2.5   
 1:00 3.0    
2 2:00 3.0 5   
 3:00 3.0    
3 4:00 3.0 7.5   
 5:00 3.0    
4 6:00 3.0 10.0   
 7:00 3.0    
5 8:00 3.0 12.5   
 9:00 3.0    
6 10:00 3.0 15.0   
 11:00 3.0    
7 12:00 3.0 17.5   
 13:00 3.0    
8 14:00 3.0 20.0   
 15:00 3.0    
 16:00 3.0 22.5   
 17:00 3.0    
 Recovery     
 1:00  0   
 2:00  0   
 3:00  0   
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Appendix G: BFF Nutrition and Physical Activity Education Outline 
BFF Intervention: Physical Activity Lesson Plan Outline 
Session 1: 
 
A. Welcome – Staff introduction and background. 
BFF Study overview and requirements 
B. Introduction to the ACSM guidelines. 
C. Review and Goal Setting – what do we want to accomplish in our time? 
1. Each participant set one goal. 
2. Brainstorm on how to accomplish this goal. 
3. Review of today’s topics. 
4. Have participants keep a food and exercise log. 
Handouts Needed: 
“Following the DASH Eating Plan” (from the DASH diet website) 
Copies of food and exercise logs 
 
Session 2: 
A. Welcome Back! – Weigh In 
1. Review of last week – Calculate step goals 
2. Discussion of goal achievement. 
3. Overview of Session 2. 
B. ACSM Guidelines-Meetings those guidelines 
C. Types of exercise. 
 
Session 3: 
A. Welcome – Weigh In/Charts 
1. Review of last week. 
2. Discussion of goal achievement. 
3. Overview of session 3. 
B. Common myths of exercise.  
C. Pros/Cons 
D. Barriers to exercise/overcoming barriers 
E. Wrap-up 
 
Session 4: 
A. Welcome-Weigh In/Charts 
1. Review of last week. 
 2. Discussion of goal achievement. 
 3. Overview of session 4. 
 B. Fun Fact – Gaining muscle and burning fat 
C. FITT Principle 
D. Exercise Sheets-Abdominals, Arms/Shoulders, Lower-body 
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Session 5:  
A. Welcome-Weight In/Charts 
1. Review of last week – try any new exercises 
B. Build up those muscles – Anaerobic Activity 
C. Machine Weights vs. Free Weights 
 
Session 6: 
A.  Welcome-Weigh In/Charts 
1. Review of last week. 
 2. Discussion of goal achievement. 
 3. Overview of session 5. 
B. Warm up /Cool Down 
1. Anaerobic activity 
2. Warm-up routines (samples) 
C. Stretching-Importance 
D. Stretching Sheet 
 
Session 7: 
A. Welcome-Weight In/Charts 
1. Review of last week. 
2. Discussion of goal achievement. 
3. Overview of session 6. 
B. Putting it all together 
1. Programs 
2. Beginner vs Intermediate/Advanced 
3. Examples 
 
Session 8: 
A. Welcome-Weigh In/Charts 
1. Review of last week. 
2. Discussion of goal achievement. 
3. Overview of session 7. 
B. Exercise Program 
1. Maintaining Weight 
2. Activity vs Food 
C. Review 
1. Review of previous sessions (any questions) 
2. Were goals achieved? 
3. Maintaining the weight loss 
4. Congratulations! 
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BFF Intervention: Dietary Education Lesson Plan Outline 
Session 1: Introduction to BFF Study and DASH Diet 
A. Welcome – Staff Introduction and Background 
a. BFF study review and background 
B. Introduction to dietary guidelines for CHD - DASH Diet 
C. Review Goal Setting – what do we want to accomplish in our time? 
1. Each participant set a goal 
2. Review today’s topics 
3. Have participants keep food and exercise log 
Handouts need: 
Following the DASH Eating Plan” (from the DASH diet website) 
“Making the DASH Difference” 
 “Healthy Eating the DASH Way” 
“Get Smart About Salt” 
Copies of food and exercise logs 
 
Session 2: Cutting Calories, Healthy Food Substitutions, Eating in Dining Halls 
A. Welcome back! – Collect pedometer sheets 
1. Review of last week – DASH diet 
2. Overview of today’s session  
B. Review Food logs 
a. Compare their log to DASH sample day 
C. Review Goal setting  
a. Each participant set a goal 
b. Review today’s topics 
Handouts needed: 
“How to Lower Calories on the DASH Eating Plan” 
“Healthy Food Substitutions From Dining Hall” 
Sample Day from DASH Website 
 
Session 3: Know Your Fats 
A. Welcome back! 
1. Review of last week – Nutrient Density, Cutting Calories 
2. Overview of today’s session 
B. Review Goal Setting 
a. Each participant set a goal for next week 
b. Have goal be related to topics discussed in today’s session 
c. Encourage participants to engage in 30 minutes physical activity/day 
C. Review Take Home Message 
a. Fun Food Fact 
 
Handouts Needed: 
“Heart Friendly Fats” (from SNAP office) 
  
152 
 
“The Truth About Trans Fats” (from SNAP office) 
“Cutting Down Your Cholesterol” (from SNAP office) 
 
Session 4: Grains 
A. Welcome back! 
1. Review of last week’s topic 
2. Overview of today’s session 
B. Review Goal Setting 
a. Each participant set a goal for next week 
b. Replace one common food they eat that is not whole grain with a whole 
grain option 
C. Review Take Home Message 
a. Fun Food Fact 
 
Handouts Needed: 
“Go for Whole Grains” – Nutrition to GO 
 
Session 5: Fruits and Vegetables 
A. Welcome back! 
1. Review of last week’s topic 
2. Overview of today’s session  
B. Review Goal Setting  
a. Each participant set a goal for next week 
b. Encourage participants to engaged in 30 min physicial activity/day 
c. Fun Food Fact  
C. Review Take Home Message 
 
Handouts Needed: 
“The Power of Produce” (SNAP office) 
“Fantastic Fruits” (SNAP office) 
“Very Veggies” (SNAP office) 
 
Session 6: Protein 
A. Welcome back! 
1. Review of last week’s session 
2. Overview of this week’s session 
3. DASH diet recommendations for protein 
B. Review Goal Setting 
a. Each participant set a goal for next week 
b. Encourage physical activity 
c. Fun Food Fact 
C. Review Take Home Message 
 
Handouts Needed: 
“An Egg-Cellent Choice” (from SNAP office) 
“Fast Seasonal Facts” (from SNAP office) 
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Session 7: Dairy 
A. Welcome back! 
1. Review of last week’s session 
2. Overview of this week’s session 
3. DASH diet recommendations/servings 
B. Review of All Nutrition Sessions up to this point 
a. Discuss key points 
b. Review principles of DASH Diet 
C. Review Goal Setting 
a. Each participant set a goal for next week 
b. Encourage physical activity 
c. Fun Food Fact 
D. Review Take Home Message 
E. Feedback from group on sessions 
 
Handouts needed: 
“Got Calcium?” (from SNAP office) 
“Lactose Intolerance” (from SNAP office) 
“BFF Nutrition Session Guide” 
 
 
Session 8: Maintenance of Lifestyle Changes and Weight Loss 
A. Welcome back! 
1. This is the last diet session; thank everyone for sticking through the 
diet sessions 
2. Review of last week’s session 
B. Overview of this week’s session 
a. Tips to Maintain the Diet and Exercise Changes 
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Appendix H: Hatch Consent Form for Research 
The University of Rhode Island 
Department of Nutrition and Food Sciences 
302 Ranger Hall 
Nutritional Assessment and Chronic Disease Risk Factor Identification in Young 
Adults  
 
CONSENT FORM FOR RESEARCH 
Thank you for considering being part of our study, Nutritional Assessment and 
Chronic Disease Risk Factor Identification in Young Adults.  By participating in this 
research, you will help us determine what risk factors of chronic disease are present in 
young adults.  To participate in this research, you must be a first-year University of 
Rhode Island student between the ages of 18 and 24 years, and you may not be 
pregnant or lactating.  You are not eligible for this study if you have diabetes (Type I 
or Type II), cancer, coronary heart disease, liver disease, a bleeding disorder, or if you 
are on lipid-lowering medications.  
 
Description of the project: 
You have been asked to take part in a research study aimed at determining what 
chronic disease risk factors are present in a college population 18 to 24 years of age.  
The presence of chronic disease risk factors will be determined by taking 
measurements and dietary information during three visits and two phone calls over a 
six to eight week period. 
 
What will be done: 
If you decide to take part in this study, this is what will happen over the course of 
three visits and two phone calls: 
 
First assessment visit (approximately 20-30 minutes): 
• We will ask you questions about what you ate the day before.  You do not need 
to write anything down prior to coming.  
 
Day prior to second screening visit (overnight): 
• For the twelve hours prior to the second assessment visit in Ranger 301, you 
will be asked to refrain from eating or drinking anything unless it’s water.  We 
encourage you to drink as much water as you would like.  For example, if your 
screening visit is scheduled for 8 am on a Tuesday, you will not eat or drink 
anything except for water after 8 pm on Monday evening. 
 
The second assessment visit (approximately 20-30 minutes): 
• Your height, weight, and waist circumference will be measured. 
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• After you have been fasting for 12-hours, 60-ml blood draw (approximately 4 
tablespoons) will be taken while you are in a seated position.  We will use your 
blood to measure different things in your blood such as lipids (example: total 
cholesterol), hormones (example: insulin), and protein (example: 
apolipoproteins).   
• You will complete questionnaires on your personal and family medical history, 
your daily activity and exercise routine, and how hungry you are.  You may 
skip any question(s) in the surveys. 
 
Day prior to third assessment visit (overnight): 
• As with the day prior to the second assessment visit, you will be asked to 
refrain from eating or drinking anything unless it’s water for the twelve hours 
prior to the second screening visit in Ranger 301.  Again, we encourage you to 
drink as much water as you would like. 
 
 
The third assessment visit (approximately 15 minutes): 
• Blood pressure will be measured two times on the right arm while you are in a 
seated position. 
• A 12 hour fasting 10-ml blood draw (approximately 1 tablespoon) will be 
taken while you are in a seated position. 
 
After the third assessment visit, you will receive two phone calls from study staff.  
During these two phone calls you will answer questions about the foods you eat.  Each 
of these phone calls will take approximately 20-30 minutes. 
 
From the time of the first assessment visit until the final phone call will be 
approximately six to eight weeks and a total of 2 hours of time on your part. 
 
Risks or discomfort: 
There are no known risks for the following procedures: completing the questionnaires 
and having height, weight, and waist circumference measured. Even though 
experienced personnel will perform the blood draw using a sterile technique there are 
a few risks associated with the procedure:  discomfort from the needle, bruising, 
formation of a blood clot, and infection.  A trained professional will perform the blood 
draw, and we will take all steps possible to minimize the risks to you.   
 
Benefits of this study: 
This study will help in understanding what chronic disease risk factors are most 
prevalent in a young adult population.  The direct benefits to you include learning 
about your health status.  You will receive the results with your blood pressure and the 
fats in your blood (total cholesterol, low density lipoprotein cholesterol, high density 
lipoprotein cholesterol, and triglycerides).  You will also be provided with your weight 
and body mass index status.  Although these values are not diagnostic, the results can 
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be shared with a health practitioner and repeated if deemed necessary.  If your blood 
pressure or total cholesterol, low density lipoprotein cholesterol, high density 
lipoprotein cholesterol or triglycerides do not fall within recommended values, you 
will be encouraged to follow-up with your primary care physician or at Student Health 
Services. 
 
Confidentiality: 
Your participation in this study is confidential. When you enroll in the study, you will 
be assigned a code.  This code will be used for data management only and your results 
will not be associated directly with your name.  The researchers and the University of 
Rhode Island will protect your privacy, unless they are required by law to report 
information to city, state or federal authorities, or to give information to a court of law.  
All records, including data and consent forms, will be stored in a locked office that is 
not accessible except for personnel involved in the study. 
 
In case there is any injury to the subject: 
If you have any injury or discomfort as a result of the experiment, you should notify 
Dr. Ingrid Lofgren at (401) 874-5706. Additionally, if this study causes you any 
injury, you should write or call the office of the Vice Provost for Graduate Studies, 
Research and Outreach, 70 Lower College Road, University of Rhode Island, 
Kingston, Rhode Island, telephone: (401) 874-4328. 
 
Decision to quit at any time: 
The decision to take part in this study is up to you. You do not have to participate. If 
you decide to take part in the study, you may quit at any time. Whatever you decide 
will in no way penalize you.  If you wish to quit, you simply inform Dr. Ingrid 
Lofgren at (401) 874-5706 of your decision. 
 
Incentives 
You will receive full compensation ($30.00) if you complete the study. 
 
Rights and Complaints: 
This study is part of research being conducted by the University of Rhode Island.  If 
you have any questions or if you are not satisfied with the way this study is performed, 
you may discuss your complaints with Dr. Ingrid Lofgren (401) 874-5706, 
anonymously, if you choose. In addition, you may contact the office of the Vice 
President for Graduate Studies, Research and Outreach, 70 Lower College Road, 
University of Rhode Island, Kingston, Rhode Island, telephone: (401) 874-4328. 
 
You have read the Consent Form.  Your questions have been answered.  Your 
signature on this form means that you understand the information and you agree to 
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participate in this study.  
 
I, 
____________________________________________________________________ 
residing at ________________________________________________ (zip) 
_________  
telephone __________________________ age __________ (date of birth) 
______________ 
agree to participate in this research project. 
 
________________________  ________________________ 
Signature of Participant   Signature of Researcher 
_________________________  ________________________ 
Typed/printed Name    Typed/printed name 
 
__________________________  _______________________ 
Date      Date 
 
Please sign and date two consent forms, keeping one for yourself.  
 
  
 
Appendix I: Hatch Assessment Materials 
  
CONTACT INFORMATION: 
 
NAME: Last, First Gender (circle)     Male         Female 
BIRTHDATE (mo/day/yr):  How did you hear of this study? 
MAJOR: 
 
Are you willing to be contacted after the study is over to 
evaluate the program? (circle)      Yes          No 
CURRENT ADDRESS: 
 
 
HOME ADDRESS OR CONTACT INFORMATION IN CASE YOU MOVE: 
 
 
DAY PHONE # (with area code): 
 
CELL PHONE # (with area code): 
 
 
EMAIL ADDRESS: 
BEST WAY TO CONTACT (check any applicable box):   email   day phone   cell phone   Other, specify: 
 
METHOD OF RECRUITMENT (explain how subject was recruited): 
 
NOTE: The following is for compensation purposes. 
NAME: Last, First 
 ID # 
Assessment #1 Assessment #2 In-person recall 
Phone recall 1 
Phone recall 2 
*Compensation given upon 
completion of final recall*   
 
 
  
PPT Signature 
 
 
 
 
 
 
 
Researcher Initials 
 
Date 
Notes:    
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Data Collection Form 
Subject ID #
DATE
TIME
RESEARCHER who 
completed assessment
Measure 
1
Measure 
2
Average of
1 & 2
Measure 
1
Measure 
2
Average of
1 & 2
WEIGHT (kgs) *
N/A N/A
HEIGHT (cm) *
N/A N/A
BP (systolic/diastolic) * *
WAIST CIRCUMFERENCE (cm) *
N/A N/A
BMI
N/A N/A
In-person recall? (circle)
CONCERNS FOR ERROR (for weight, 
height, bp, waist circum., other)
COMMENTS    
* Calculate average of the two measurements
Assessment visit #1 Assessment Visit#2
Blood Pressure Readings:  ________    ________    ________    ________    ________    ________
If applicable:  Date Subject becomes inactive _____________.   Date Subject changes from inactive to active _______________.   
If applicable:  Date Subject becomes a drop-out ____________. 
Date Subject becomes inactive _____________.   Date Subject changes from inactive to active _______________.
yes/no yes/no
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INTERNATIONAL PHYSICAL ACTIVITY 
QUESTIONNAIRE 
(August 2002) 
 
SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT 
 
FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 
years) 
 
The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 
questionnaires. Long (5 activity domains asked independently) and short (4 generic 
items) versions for use by either telephone or self-administered methods are 
available. The purpose of the questionnaires is to provide common instruments that 
can be used to obtain internationally comparable data on health–related physical 
activity. 
 
Background on IPAQ 
The development of an international measure for physical activity commenced in 
Geneva in 1998 and was followed by extensive reliability and validity testing 
undertaken across 12 countries (14 sites) during 2000.  The final results suggest that 
these measures have acceptable measurement properties for use in many settings 
and in different languages, and are suitable for national population-based prevalence 
studies of participation in physical activity. 
 
Using IPAQ  
Use of the IPAQ instruments for monitoring and research purposes is encouraged. It 
is recommended that no changes be made to the order or wording of the questions 
as this will affect the psychometric properties of the instruments.  
 
Translation from English and Cultural Adaptation 
Translation from English is supported to facilitate worldwide use of IPAQ. Information 
on the availability of IPAQ in different languages can be obtained at  www.ipaq.ki.se. 
If a new translation is undertaken we highly recommend using the prescribed back 
translation methods available on the IPAQ website. If possible please consider 
making your translated version of IPAQ available to others by contributing it to the 
IPAQ website. Further details on translation and cultural adaptation can be 
downloaded from the website. 
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Further Developments of IPAQ  
International collaboration on IPAQ is on-going and an International Physical 
Activity Prevalence Study is in progress. For further information see the IPAQ 
website.  
 
More Information 
More detailed information on the IPAQ process and the research methods used in the 
development of IPAQ instruments is available at www.ipaq.ki.se and Booth, M.L. 
(2000).  Assessment of Physical Activity: An International Perspective.  Research 
Quarterly for Exercise and Sport, 71 (2): s114-20.  Other scientific publications and 
presentations on the use of IPAQ are summarized on the website. 
 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
We are interested in finding out about the kinds of physical activities that 
people do as part of their everyday lives.  The questions will ask you about the 
time you spent being physically active in the last 7 days.  Please answer each 
question even if you do not consider yourself to be an active person.  Please 
think about the activities you do at work, as part of your house and yard work, 
to get from place to place, and in your spare time for recreation, exercise or 
sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  
Vigorous physical activities refer to activities that take hard physical effort and 
make you breathe much harder than normal.  Think only about those physical 
activities that you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous 
physical activities like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical 
activities on one of those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
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Think about all the moderate activities that you did in the last 7 days.  
Moderate activities refer to activities that take moderate physical effort and 
make you breathe somewhat harder than normal.  Think only about those 
physical activities that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate 
physical activities like carrying light loads, bicycling at a regular pace, or 
doubles tennis?  Do not include walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
4. How much time did you usually spend doing moderate physical 
activities on one of those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
 
Think about the time you spent walking in the last 7 days.  This includes at 
work and at home, walking to travel from place to place, and any other walking 
that you might do solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
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The last question is about the time you spent sitting on weekdays during the 
last 7 days.  Include time spent at work, at home, while doing course work 
and during leisure time.  This may include time spent sitting at a desk, visiting 
friends, reading, or sitting or lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a 
week day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
This is the end of the questionnaire, thank you for 
participating. 
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Participant Feedback      Name:  
The following is a summary of your results from the Nutrition Assessment Study.  We 
are sorry for the long delay in getting these results to you.  We had some equipment 
problems that were just resolved.  We would like to restate that these values are used 
for screening purposes only and not for diagnosis.  We encourage you to follow up 
with your primary care physician if you have concerns about your values.  If you have 
questions about the data or the study, please call us at 401-874-2785. 
 
Height:         cm      Weight:      kg  
Waist Circumference:       cm    BMI:          kg/m2 
 
BMI Classifications: 
 Underweight: <18.5 kg/m2   Normal: 18.6-24.9 kg/m2 
 Overweight: 25-29.9 kg/m2   Obese: >30 kg/m2 
Blood Pressure:         mmHg 
 
Blood Pressure Classifications:   
Optimal = <120/<80 mmHg 
        Pre-hypertensive = 120-139/80-89 mmHg 
        Hypertensive = >140/>90 mmHg 
 
Average Total Calories Consumed:  
% Carbohydrate: %  % Protein: %  % Fat: % 
 
Blood Lipid Values 
Total Cholesterol:       mg/dL   LDL-Cholesterol:        mg/dL 
Triglycerides:             mg/dL   HDL-Cholesterol:        mg/dL 
Blood Lipid Recommendations: 
Total Cholesterol: <200mg/dL LDL-Cholesterol: <130 mg/dL 
Triglycerides: <150 mg/dL             HDL-Cholesterol:  Females >50 mg/dL 
             Males >40 mg/dL 
   
 
